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Research indicates that cognitive impairment in multiple sclerosis (MS) may occur in 
approximately half of cases and may have detrimental effects on an individual’s general 
health status and mood. This study explores the usefulness of subjective measures of 
cognitive impairment in enhancing our knowledge of the relationships between these 
variables. Of particular interest was the self-reporting of executive dysfunction, an 
under-researched area in MS.
Method
One hundred and forty-seven individuals with MS completed a postal questionnaire 
survey measuring self-reported memory impairment, executive dysfunction, mood and 
health status. Eighty-two of their relatives completed a postal questionnaire survey, 
rating the patients’ memory impairment and executive dysfunction. Comparative 
samples were a traumatic brain injury (TBI) population and healthy controls.
Results
The amount of executive dysfunction reported by patients was lower than in a TBI 
population but not significantly different from that reported by healthy controls. 
Relatives reported lower levels of executive dysfunction than in a TBI population but 
significantly higher levels than healthy controls. There was no significant difference 
between patient and relatives’ reports of executive dysfunction in the group overall but 
detailed analyses highlighted sub-groups where significant differences were found. The 
sample was split into individuals who over-report and under-report executive
Vlll
difficulties in comparison to their relatives. Over-reporters were found to be more likely 
to have relapsing-remitting MS, report higher levels of anxiety, report higher levels of 
memory impairment and have lower levels of relative-reported memory impairment, 
compared to under-reporters. The discrepancy score (a tendency to over-report 
executive dysfunction) was also found to be a predictor of depression. Subjective 
reports of cognitive impairment were not found to predict health status (measured by 
social functioning and employment status). However, self-reports of executive 
dysfunction were found to be the strongest predictors of depression and anxiety.
Conclusions
These results are interpreted and possible implications for theory and clinical practice 
suggested. The findings highlight relationships between subjective reports of cognitive 
impairment and mood and health status that have not been investigated before in MS. A 
number of hypotheses are proposed for the relationship between these variables, but 
clarification of these relationships is not possible in the current design. Therefore, 
avenues are suggested for future research.
IX
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1. INTRODUCTION
1.1 OVERVIEW
Over the last twenty years there has been an increasing awareness that cognitive 
impairment has a significant prevalence in multiple sclerosis (MS). This study aims to 
investigate the prevalence of self-reported executive and memory difficulties in a 
sample of individuals with MS and to explore the relationship between these subjective 
reports and health status and mood. The introduction details the clinical features of MS 
and describes the common effects of MS, focusing specifically on cognitive impairment. 
It introduces the concept of executive dysfunction and reviews the literature on 
executive dysfunction in MS. The literature describing the relationship between 
cognitive impairment and other MS disease factors is discussed, and the relationship 
between cognitive impairment and health status and mood is also described, 
highlighting gaps in the current research. The paradigms used to measure cognitive 
impairment are critically evaluated, focusing specifically on the use of subjective 
measures. The rationale and aims of the study are presented and a number of hypotheses 
specified for testing.
1.2 MULTIPLE SCLEROSIS: THE CLINICAL PICTURE
1.2.1 Prevalence
MS is the most common cause of severe neurological disability in young adults in the 
UK, occurring in approximately 0.1% of the population (British Society of 
Rehabilitation Medicine (BSRM), 1993). MS occurs mostly in individuals aged 15-50
1
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years old, however the average age of occurrence of first symptoms is 30 years old 
(Sibley, 1990). It is twice as common in females (Sibley, 1990).
1.2.2 Pathology
MS is a progressive neurological disease of the central nervous system (CNS). An 
immunological response is thought to lead to multi-focal attacks on axons within the 
CNS, leading to the destruction of myelin and the death of oligodentrocytes (myelin- 
producing cells). This leads to the formation of lesions (sclerotic plaques) on the axons 
(Mohr and Cox, 2001), which disrupt the transmission of nerve impulses. The lesions 
ultimately lead to axonal loss and brain atrophy. Lesions are particularly common in the 
brainstem, spinal cord and optic nerves, although they can be scattered throughout the 
white matter (Zakzanis, 2000). As a result, the effects of MS are broad ranging and the 
clinical presentation can be very variable.
1.2.3 Clinical course
There are four clinical courses in MS: benign, relapsing-remitting, secondary- 
progressive and primary-progressive. These subtypes are characterised by distinct 
patterns of disability over time (see Figure 1).
2
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Approximately 10-15% of MS cases follow a benign course (Mohr and Cox, 2001) (see 
Figure la), characterised by relatively few periods of exacerbation with complete 
recovery and little or no disability. The most common course is relapsing-remitting (see 
Figure lb), which occurs in approximately 40% of cases (MS-Network, 2000). It is 
characterised by unpredictable episodes of relapse followed by remission, with or 
without complete recovery. A relapse lasts at least 24 hours and most commonly 
continues for 4-12 weeks (Sibley, 1990). Approximately 85% of MS cases will begin 
with a relapsing-remitting course (Weinshenker, 1994). However, over time, recovery 
from the relapse may diminish, leading to an accumulation of disability. Within 10 years 
of diagnosis, approximately 30-40% of relapsing-remitting cases will develop a 
secondary-progressive course and after 10 years, approximately 50-60% will develop a
3
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secondary-progressive course (Weinshenker, 1994). Secondary-progressive MS (see 
Figure lc) follows a similar course, except that recovery is incomplete and disability 
usually progresses between relapses. Because relap sing-remitting MS frequently 
becomes secondary-progressive, Mohr and Cox (2001) describe both subtypes together 
as constituting 65-70% of all cases. Finally, approximately 10-15% of MS cases are 
primary-progressive (see Figure Id), characterised by disease progression from the 
outset, with no or rare relapses (Sibley, 1990).
1.2.4 Diagnosis
Diagnosis of MS, especially in its early stages, is problematic since it requires evidence 
of signs and symptoms in multiple sites within the CNS, with changes over time 
(Brassington and Marsh, 1998). Magnetic Resonance Imaging (MRI) is the preferred 
method of imaging for the diagnosis of MS, highlighting gross axonal damage. 
Measurement of evoked potentials may provide evidence of abnormal axonal 
conduction, and examination of the cerebro-spinal fluid (CSF) via lumbar puncture may 
reveal elevated immunoglobulin-G in the CSF. These investigations are used in addition 
to neurological examination to provide evidence in support of an MS diagnosis. Poser et 
al1 (1983) detail diagnostic criteria for MS, with two groups of cases (definite and 
probable MS) and two subgroups within these (clinically or laboratory-supported). The 
diagnostic criteria were recently revised and the terms simplified (McDonald et al, 
2001). The recommended terms are now either “MS”, “possible MS” or “not MS”.
1 Following BPS guidelines, where references contain more than five authors they are not included in the 
text.
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1.2.5 Aetiology
The aetiology of MS is not clearly understood. However, proposed hypotheses include a 
slow-acting virus, a delayed reaction to a virus, or an autoimmune problem (Sibley, 
1990). There is evidence for a genetic component, with first-degree relatives being 6-8 
times more at risk than the general population and also evidence for the role for 
environmental factors, with MS prevalence rates being significantly lower near the 
equator (Thompson, 1996).
1.3 THE CONSEQUENCES OF MULTIPLE SCLEROSIS
Although there is considerable heterogeneity between individuals, the BSRM (1993) 
report that individuals with MS typically experience multiple severe physical, sensory, 
cognitive and emotional problems.
1.3.1 Physical effects
The BSRM state that 70% experience problems with loss of limb function and 
sensation; 35% experience problems with bladder or bowel functioning and 70% 
experience visual disturbance. Fatigue is also common, being reported in 90% of 
individuals with MS (Krupp, Alvarez, LaRocca, and Scheinberg, 1988). Other common 
symptoms include sexual dysfunction, loss of balance and pain (Mohr and Cox, 2001).
1.3.2 Psychological effects
"Having MS means living with uncertainty and adapting to changing situations ” (MS 
Society, 2000, pi). An important feature of the disease from the patient’s perspective is 
its unpredictability. For an individual following diagnosis, it is not possible to predict
5
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disease course. Aronson (1997) suggests that an unstable disease course is associated 
with poorer quality of life. Individuals with primary-progressive MS have been found to 
have better psychological functioning than those with other types (Vleugels et al, 1998) 
and one hypothesis for this is that the disease course is more predictable and, therefore, 
easier to adjust to.
Minden, Orav and Reich (1987) found that 54% of MS patients showed signs of 
psychopathology, including affective disturbances (principally depression and anxiety, 
but also bipolar disorders, manic episodes, euphoria and emotional lability), psychoses 
and personality changes. Depression is more common in MS compared to “normal” 
populations and other medical disorders (Minden et al, 1987). Lifetime prevalence of 
major depressive disorder following MS diagnosis is approximately 50% and the suicide 
rates are 7.5 times greater than the normal population (Sadovnick, Eisen, Ebers and 
Paty, 1991). The aetiology of depression is uncertain, with hypothesised contributions of 
neurological pathology, cognitive deficits and social stresses (Gilchrist and Creed, 
1994). Anxiety is also common in MS (Stenager, Knudsen and Jensen, 1990), although 
it is relatively under-researched. Freed (1997) suggests that anxiety may be related to 
unpredictability, uncertainty about the future, dealing with new symptoms, the 
progressive nature of the disease and the lengthy diagnostic process. Euphoria is a well- 
recognized symptom of MS although it occurs rarely. Foong et al (1997) suggest it is 
likely to be a clinical expression of executive dysfunction.
6
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1.3.3 Cognitive impairment in multiple sclerosis
1.3.3.1 Prevalence o f cognitive impairment
Although MS has been recognised and described for over one hundred years (Charcot, 
1877), recognition and investigation of related cognitive impairment has occurred only 
in the last 20 years. Controversy and disagreement exist regarding the exact nature of 
cognitive impairment and its implications. Despite this, the literature is fairly consistent 
in recognising that some individuals with MS do have difficulties with cognitive 
functioning.
Using neuropsychological assessment, Rao, Leo, Bemardin and Unverzagt (1991a) 
report the incidence of cognitive impairment in clinical samples of MS patients to be 
between 54 and 65% and within a community sample to be 43%. Ron, Callanan and 
Warrington (1991) report general cognitive difficulties with memory, attention, 
conceptual reasoning, verbal fluency and abstracting abilities, with relative sparing of 
language functions. Similarly, Rao et al (1991a) report significant differences between 
MS patients and controls on recent memory, sustained attention, verbal fluency, 
conceptual reasoning and visuospatial perception. The evidence for cognitive 
impairment within different cognitive domains will be reviewed individually within this 
section. In the following section, the discussion will focus particularly on the nature of 
executive dysfunction and evidence for executive dysfunction in MS.
1.3.3.2 Memory deficits
Memory deficits are the most frequently self-reported and neuropsychologically 
assessed problem in MS (Langdon and Thompson, 1996). MS seems to be particularly
7
Self-reported executive dysfunction in multiple sclerosis Introduction
associated with dysfunction in verbal memory ability and memory for complex material 
(Huber, Paulson, Shuttleworth and Chakeres, 1987). Kenealy, Beaumont, Lintem, and 
Murrell (2000) found deficits in autobiographical memory. Memory deficits have been 
described as problems with recall and working memory (Rao et al, 1993) and with 
inadequate initial leaming/acquisition (DeLuca, Barbieri-Berger and Johnson, 1994). 
DeLuca et al (1994) suggested that multiple cognitive processes are likely to influence 
the memory impairment evident in MS.
1.3.3.3 Intellectual functioning deficits
Previous research has found small but consistent differences between MS patients and 
controls on intellectual functioning (Rao, 1986). MS patients perform significantly 
worse on performance IQ, although this is likely to be related to sensori-motor 
impairment.
1.3.3.4 Speed o f information processing deficits
Rao, Aubin-Faubert and Leo (1989) found that MS patients had a significantly slower 
reaction time on a memory-scanning test. Litvan, Graffnan, Vendrell, and Martinez 
(1988) found reduced performance on the Paced Auditory Serial Addition Task. Speed 
of information processing deficits may underlie the cognitive difficulties evident in MS, 
such as performance on memory tasks. D’Esposito et al (1996) found that in MS 
patients, the ability to coordinate two concurrent memory tasks was significantly poorer 
than controls and concluded that speed of information processing deficits might be 
associated with this difficulty.
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1.3.3.5 Visuospatial deficits
Most studies have observed a dysfunction in visuospatial and visuoperceptual functions 
(Fennell and Smith, 1990), however, the tests used often require multiple brain 
functions, motor speed and dexterity, and so the implications of these results are 
unclear. On tests of pure visuospatial processing, problems seem to be related to deficits 
in planning and execution rather than visuospatial difficulties (Fennell and Smith, 
1990).
1.3.3.6 Executive dysfunction
Individuals with MS have also been found to have difficulties with executive functions. 
These are described in more detail, as they are an important focus of the current study.
1.4 EXECUTIVE DYSFUNCTION
1.4.1 Theoretical framework
Executive functions are the higher-level cognitive processes required in situations 
involving decision making, planning, adapting to novel sequences, correcting errors and 
inhibiting strong habitual responses (Shallice and Burgess, 1991). These functions are 
commonly termed frontal lobe functions, given their basis in the frontal lobes and 
connected regions. Based on models of executive functioning (e.g. Lezak, 1995 and 
Stuss and Benson, 1987), executive functions are hypothesised to be fractionated into a 
number of areas:
• Initiative and drive: motivation, impulse control, drive, emotional responsiveness 
and capacity for pleasure.
9
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• Attention: sustained attention, coping with interference, purposeful action, working 
memory, handling simultaneous sources of information, relating or integrating 
isolated detail and responding to the whole, switching attention and cognitive 
flexibility.
• Memory: voluntary recall of information, organisation of memory strategies, 
following instructions and temporally discriminating items in memory.
• Planning, strategy and execution of sequences of action: translating knowledge 
of facts into appropriate action, planning, comparing the results with the original 
intention, sequencing, decision making, anticipation, goal selection, shifting from 
one concept to another and changing a specific behaviour once started, looking 
ahead from present circumstances, viewing the environment objectively, conceiving 
alternatives and using external cues to guide behaviour.
• Self-regulation in response to environmental contingencies: self-regulation, self­
monitoring, self-correction, self-awareness, meta-cognition, dealing with oneself in 
relation to the environment, effective performance and using information to 
influence behaviour.
1.4.2 Clinical manifestations of executive dysfunction
Executive dysfunction is a common problem following traumatic brain injury (TBI) 
because TBI is particularly associated with damage to the frontal lobes (Prigatano and 
Schacter, 1991). Consequently, the majority of research has therefore been conducted in 
TBI populations. However, these findings will have relevance to the study of other 
populations who may experience frontal lobe damage, such as MS patients. The findings
10
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of this research are described, followed by some limited research in other populations 
and, finally, the evidence for executive dysfunction in MS.
1.4.2.1 Common symptoms o f executive dysfunction
Executive functions encompass a broad range of cognitive functions and the behavioural 
consequences of any impairment will vary between individuals. However, common 
behavioural consequences include “personality change” resulting from disinhibition, 
lability, irritability, egocentricity and impulsivity, as well as resulting anger and 
frustration. Common symptoms also include poor planning and sequencing, poor self­
monitoring, organizational problems, concrete thinking, stereotyped actions and poor 
judgement. Alderman and Ward (1991) describe individuals with executive dysfunction 
as being impulsive, distractible, having problems utilizing feedback and behaving 
inappropriately in social situations. Such difficulties will have a direct impact on their 
ability to maintain independent living and previous vocational and social activities.
A common element of executive dysfunction is reduced insight and self-awareness 
(Lezak, 1995). Individuals with TBI consistently underestimate cognitive (Tyerman, 
1987), personality (Tyerman, Booth and Young, 1994) and family and lifestyle 
difficulties (Young, 1994) post-injury, in comparison to their relatives’ ratings. 
Individuals with TBI are commonly unable to accurately judge their own behaviour, for 
example in vocational or social situations. This may lead to confusion, social isolation 
and sometimes delusional ideas (Prigatano and Schacter, 1991). This has an impact on
rehabilitation outcome and successful independent living, because individuals with
0
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reduced insight may be unable to fully compensate for their impairments by adapting 
their behaviour and environment (Prigatano and Schacter, 1991).
Reduced insight is likely to be related to damage in the frontal and temporal lobes. 
Prigatano and Altman (1990) found that the group of patients with the greatest lack of 
insight had a greater number of lesions and a higher incidence of bilateral cerebral 
lesions. Stuss (1991) suggests that frontal lobe damage results in a breakdown of a 
multiple-domain awareness system, and leads to reduced access to the knowledge 
contained in specific domains (as lack of insight is rarely complete). However, apparent 
lack of insight is not always due to organic damage. Kihlstrom and Tobias (1991) 
discuss the differences between lack of awareness (due to neurological damage), denial 
(where the individual represses or is unable to accept difficulties due to psychological 
factors), and indifference (where the individual is aware but appears to be disinterested).
Although these symptoms of executive dysfunction are more common in those with 
extensive frontal lobe damage, such as TBI populations, they are also relevant to other 
populations who may experience more diffuse damage.
1.4.3 Evidence for executive dysfunction in other disorders
Symptoms associated with executive dysfunction have been noted in other disorders, 
such as dementia and schizophrenia. For example, McPherson, Fairbanks, Tiken, 
Cummings and Back (2002) investigated apathy (a common behavioural disturbance in 
Alzheimer's disease) and linked it to impaired performance on tests of executive 
functioning. Castellon, Hinkin and Myers (2000) found evidence of executive
12
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dysfunction (difficulties with dual tasks and inhibition of responses) in individuals with 
HIV and found impaired test performance to be related to apathy and irritability. 
Common symptoms of schizophrenia, such as impaired motivation and poor insight 
have also been found to be related to frontal lobe dysfunction (McGlynn and Schacter, 
1997) and to impaired performance on tests of executive functions (Young, Davila and 
Scher, 1993). In their review paper, McGlynn and Schacter (1997) conclude that 
unawareness of deficits in schizophrenia and dementia depends on patterns of brain 
impairment involving the frontal lobes. This is relevant to the study of MS, in which 
lesions may present in the frontal lobes or connecting regions. The investigation of 
executive dysfunction in MS is, therefore, an important issue.
1.4.4 Evidence for executive dysfunction in multiple sclerosis
It is only recently that executive functions in MS have been investigated in 
neuropsychological studies (Foong et al, 1997). Such research has consistently found 
deficits in some elements of executive functioning. Some of the research described in 
the previous sections on cognitive impairment in MS, such as difficulties with planning 
and execution of visuospatial tasks and difficulties with attention and working memory 
can be related to difficulties with executive functions. More specific evidence is detailed 
below.
There is extensive research indicating difficulties with attentional processes in MS. 
Foong et al (1997) report deficits in spatial working memory, cognitive flexibility and 
switching attention. Fennell and Smith (1990) also report deficits in focal and sustained
13
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attention. There is also evidence for impaired verbal working memory (digit span) 
(Huber et al 1987).
There is evidence for the role of executive dysfunction in MS memory impairment. 
Beatty, Goodkin, Beatty, and Monson (1989) suggest that, although MS patients do have 
mild deficits in retrieval of information, the extent of memory impairment seen in MS is 
related to inefficiency in the use of semantic encoding and a failure to use effective 
memory strategies - elements of executive function. Similarly, Scarrabelotti and Carroll 
(1999) suggest that MS memory deficits primarily involve an impaired ability to apply 
intentionally directed thinking processes to a memory task.
Studies of individuals with MS have found deficits in abstract concept formation, 
(Brassington and Marsh, 1998). Beatty, Hames, Blanco, Paul, and Wilbanks (1995) 
found that individuals with MS performed more poorly on tests of verbal abstract 
reasoning than controls, although Rao (1986) found no difference. Foong et al (1997) 
found reduced planning ability on the Tower of London task. Beatty et al (1989) used 
the Wisconsin Card Sorting Test (WCST) with MS patients. They found that MS 
patients did not have problems with non-perseverative errors, trials to first category or 
failures to maintain set, but they did have more perseverative errors, i.e. the MS patients 
had difficulties where problems involved abandoning formerly correct hypotheses. 
However, in a further study, Beatty and Monson (1996) compared performance on the 
WCST and the Californian Card Sorting Test (which allows more specific analysis of 
perseverative performance), and concluded that MS patients did not have a problem 
with perseveration, but had specific difficulties with concept formation. Beatty and
14
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Monson (1994) also found that MS patients were impaired on picture sequencing tasks, 
but performed normally on a purely motor-sequencing test, indicating sequencing as a 
cognitive deficit. Reduced verbal fluency is also a commonly reported cognitive deficit 
(Brassington and Marsh, 1998).
No specific investigations of self-regulation, self-monitoring and self-awareness were 
found in the literature regarding individuals with MS. There is limited research on the 
metacognitive abilities of MS patients. Meta-memory refers to an individual’s 
knowledge about his or her memory, and is a function that seems to require both 
memory and conceptual abilities (Beatty et al, 1989). Beatty and Monson (1991) found 
that MS patients impaired in recognition memory or on the WCST had mild deficits in 
meta-memory and that those with deficits on both memory and WCST had extensive 
impairments in meta-memory. No specific studies of insight were found for individuals 
with MS, although anecdotal evidence would suggest lack of insight regarding cognitive 
and physical functioning to be a common phenomenon presented to clinicians (Langdon 
and Thompson, 1996).
1.5 RELATIONSHIP BETWEEN DISEASE VARIABLES AND COGNITIVE 
IMPAIRMENT IN MULTIPLE SCLEROSIS
Only a subgroup of individuals with MS experience cognitive impairment, and research 
has attempted to understand this by investigating the relationship between cognitive 
impairment and disease variables. Most studies have investigated general cognitive 
impairment, but where executive functioning has been specifically examined, this will 
be discussed.
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1.5.1 Disease course
There is evidence that individuals with primary-progressive MS experience significantly 
more general cognitive impairment than other subtypes. Heaton, Nelson, Thompson, 
Burks and Franklin (1985) found that 72% of patients with primary-progressive MS 
showed cognitive impairment, compared to 46% of those with relapsing-remitting MS. 
Other studies have found no influence of clinical course on cognitive functioning 
(Moller, Wiederman, Rohde, Backmund and Sonntag, 1994; Rao, Leo, Bemardin and 
Unverzagt, 1991b). There is also evidence that the prevalence of executive dysfunction 
may differ between subtypes. Mahler (1992) found that individuals with primary- 
progressive MS performed more poorly than those with relapsing-remitting MS on tasks 
involving abstract concept formation and set shifting. Foong et al (1997) found trends 
for differences between subtypes on neuropsychological tests of executive dysfunction, 
but found that individual differences lead to considerable group overlaps and overall 
non-significant results. Zakzanis (2000) reviewed evidence to date and concluded that 
individuals with primary-progressive MS experience more executive functioning 
impairments and individuals with relapsing-remitting MS experience more memory 
impairment. There is a consistent finding in the literature of a relationship between 
disease course and cognitive functioning, although the relationship may only be weak 
(Brassington and Marsh, 1998).
1.5.2 Disease duration
Although cognitive impairment has been reported in the early stages of MS, it is 
generally thought to be more prevalent in individuals with longer disease duration
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(Klonoff, Clark, Oger, Paty and Li, 1991). However, research findings are inconsistent. 
Some studies have found a significant positive relationship between general cognitive 
impairment and disease duration (e.g. Heaton et al, 1985) and others not (Rao et al, 
1991b). In a review, Zakzanis (2000) report higher levels of cognitive difficulties, 
especially increased prevalence of executive dysfunction in patients with longer disease 
duration. This relationship appears to be significant, but weak.
1.5.3 Physical disability
Mclntosh-Michaelis et al (1991) found evidence for a weak relationship between 
physical disability and general cognitive impairment, but Rao et al (1991b) found no 
significant difference in physical disability between individuals who were cognitively 
impaired and those who were cognitively intact. Foong et al (1997) found no correlation 
between physical disability and tests of executive function.
1.5.4 Pathology
Feinstein, Ron and Thompson (1993) found number of cerebral lesions to be strongly 
correlated with general cognitive impairment, as measured by neuropsychological 
functioning. Arnett et al (1994) found a relationship between frontal lobe lesions and 
impaired conceptual reasoning. Nocentini et al (2001) and Foong et al (1997) found 
cognitive deficits to be correlated with frontal lobe lesion. However, both were unable 
to find relationships between pathology and specific cognitive deficits and Beatty (1993) 
suggests that the extent of diffuse brain damage may be more important than the specific 
site of damage. The relationship between pathology and cognitive impairment is far
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from clear and there is limited evidence that MRI lesion load predicts cognitive 
performance (Foong et al, 1997).
1.5.5 Conclusions
Research generally provides some support for the hypothesis that there may be a 
relationship between cognitive impairment and disease course, disease duration and 
pathology. However, this relationship is weak at best and cognitive dysfunction cannot 
be predicted precisely from any other aspect of the disease for any individual (Langdon 
and Thompson, 1996). Currently, it is also not possible to predict which patients will 
deteriorate cognitively and the rate at which this might occur (Beatty, Scott and James, 
1993).
1.5.6 Methodological issues in this research
The severity and pattern of cognitive impairment varies greatly from patient to patient 
(Ryan et al, 1996). Due to the distribution of pathology, within a group of MS patients, 
one would expect wide variation in symptoms, with some individuals experiencing 
predominantly physical symptoms and others predominantly cognitive symptoms. This 
natural heterogeneity brings into question the validity of homogeneous samples in 
research studies. The use of heterogeneous groups of MS patients in research studies is 
likely to be an important factor in the lack of clear relationships found between disease 
variables and cognitive impairment.
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1.6 THE IMPACT OF COGNITIVE IMPAIRMENT IN MULTIPLE 
SCLEROSIS
Brassington and Marsh (1988) suggest that the most critical question from the patients’ 
perspective is the impact of MS on an individual’s general health status/quality of life. 
Vinck, Put, Arickx and Medaer (1997) found that MS patients reported poorer quality of 
life than individuals with rheumatoid arthritis or cancer. One of the differences between 
these diseases and MS is the presence of cognitive impairment in MS, suggesting 
cognitive impairment might be an important factor. Evidence for the relationship 
between cognitive impairment and health status and mood will be reviewed.
1.6.1 Health status
The majority of research has used objective measures of cognitive impairment, i.e. 
neuropsychological assessment. Rao et al (1991b) found that cognitively impaired MS 
patients were less likely to be working and engaged in fewer social or vocational
activities than cognitively intact individuals. They were more dependent, reported more
<
sexual dysfunction and experienced greater difficulty in performing household tasks. 
Such difficulties were irrespective of physical disability. Stenager, Knudsen and Jensen 
(1994) found that, although cognitive deficits do not correlate consistently with physical 
impairment, they do correlate with disability and handicap, particularly unemployment.
Some studies have examined the relationship between self-reported cognitive 
impairment and functional status. Edgley, Sullivan and Dehoux (1991) found that 
perceived cognitive impairment was a significant determinant of unemployment. Vinck 
et al (1997) examined the role of self-reported cognitive impairment in predicting
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quality of life. They found that quality of life was low in those with both objective and 
self-reported cognitive dysfunction. However, Higginson, Arnett and Voss (2000) found 
that, whilst only relatives’ reports of memory impairment correlated with performance 
on the Rivermead Behavioural Memory Test, neither self nor relative reports were 
predictive of functional status.
1.6.2 Mood
The relationship between cognitive impairment and mood in MS has received relatively 
little research attention. Gilchrist and Creed (1994) found cognitive impairment to be 
more frequent in subjects diagnosed with depression and that depressed patients 
experienced significantly more stress in occupation and family relationships. However, 
it is not possible to infer causality in these findings, due to the cross-sectional design. 
Vinck et al (1997) suggest that cognitive deficits add to the emotional problems 
associated with MS. However, Moller et al (1994) found no relationship between 
cognitive impairment and depression. Both these studies used neuropsychological 
assessment to measure cognitive impairment and there are no studies of the relationship 
between mood and self-reported cognitive impairment in MS.
1.6.3 Impaired insight
Some studies suggest that impaired insight may have an impact on the reporting of 
mood and quality of life. Kenealy et al (2000) found that patients with impaired 
autobiographical memory reported significantly better quality of life and lower levels of 
depression than those with normal autobiographical memory. They concluded that 
patients with deficits in autobiographical memory had impaired knowledge about their
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past and may be unable to make valid comparative judgements about the quality of their 
present life. Individuals with primary-progressive MS have been found to experience 
less distress and to experience greater executive dysfunction. One hypothesis for their 
reduced distress is a lack of insight into any difficulties. Support for this hypothesis is 
that physical disability has been found to cause increased distress and strain on carers, 
but not increased distress in patients (Nicholl, Lincoln, Francis and Stephan, 2001). Rao, 
Huber and Bomstein (1992) found depression scores were higher in MS patients with 
mild cognitive dysfunction compared with those with no cognitive dysfunction or severe 
deficits, suggesting that those with more severe deficits had reduced insight and 
therefore, less psychological distress.
1.7 SUMMARY
The following important factors have been highlighted:
• MS is a common neurological disease with an unpredictable and usually 
progressive course. The diagnostic process is often lengthy, the aetiology is 
unknown and there is currently no treatment. These elements make MS a 
particularly distressing chronic condition.
• The effects of MS are far-reaching and include physical symptoms (sensory and 
motor), fatigue and mood disorders (especially depression and anxiety). 
Cognitive impairment is also found and symptoms include impairments in 
memory, attention, conceptual reasoning, verbal fluency and abstracting abilities.
• There is evidence for impairment in executive functioning in MS, especially 
attentional processes, working memory, planning and strategy and concept
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formation. The prevalence and clinical presentation of executive dysfunction in 
MS has not been investigated.
• Individual variability in lesion site means that different individuals with MS may 
experience very different patterns of symptoms.
• The link between disease variables and cognitive impairment is unclear. This 
means that disease variables are currently not very useful for predicting cognitive 
impairment in individuals.
• There is some evidence that objective cognitive impairment in MS is related to 
health status and mixed evidence that subjective cognitive impairment is related 
to health status. In other clinical conditions, such as TBI, executive dysfunction 
has an impact on health status, although the specific effects of executive 
dysfunction have not been investigated in MS.
• There is mixed evidence that objective cognitive impairment in MS has a 
negative impact on mood. However, there is also some preliminary evidence to 
suggest that poor memory and lack of insight may reduce awareness of 
symptoms and, therefore, reduce self-reported distress. The relationship between 
subjective cognitive impairment and mood in MS has not been examined.
The next section will discuss the methodological issues relevant to the assessment of 
executive dysfunction in MS patients.
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1.8 PARADIGMS FOR MEASURING COGNITIVE IMPAIRMENT
1.8.1 Neuropsychological assessment in multiple sclerosis
Neuropsychological assessment provides an invaluable tool for the objective assessment 
of cognitive impairment. However, Langdon and Thompson (1996) suggest there are a 
number of problems with the use of neuropsychological assessment with MS patients. 
Physical impairments are likely to compromise sensori-motor functions on which many 
of the tests rely. Foong et al (1997) suggests that the disseminated nature of the disease 
pathology leads to general intellectual deterioration and, given the general effect of 
cerebral involvement in neuropsychological tasks, it is difficult to isolate a specific 
dysfunction. Also, fatigue, which is a common feature of MS, is likely to affect test 
performance (Krupp and Elkins, 2000).
1.8.2 Limitations of neuropsychological assessment of executive dysfunction
There are also potential problems with measuring executive dysfunction using 
neuropsychological assessment (Lezak, 1995). The test situation provides a much more 
structured environment than normal, where the individual is required to follow direct 
instructions. Such factors make it difficult to assess such skills as initiation, planning 
and sequencing. Also the testing situation may provide increased motivation, compared 
to the natural environment.
1.8.3 Ecological validity of neuropsychological assessment
The use of neuropsychological tests in general has also been examined in terms of their 
ability to predict real-life abilities, i.e. their ecological validity. Research described 
earlier provides support for a link between cognitive impairment, as measured by
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neuropsychological assessment, and health status in MS. However, the ecological 
validity of many neuropsychological tests has generally been assumed and not tested 
(Higginson et al, 2000) and some research has found that neuropsychological 
assessment is not able to adequately predict difficulties in everyday life (Richardson, 
1996). Wilson (1993) concludes that neuropsychological assessments alone “do not give 
us sufficient detail to be able to predict what kinds o f everyday problems are likely to be 
faced, nor do they tell us much about the nature and frequency o f the problems ” (p209).
A number of reasons have been suggested for why neuropsychological tests may not be 
predictive of functional status (Higginson et al, 2000). Tests may be too abstract or 
general, they may not sample the correct skills on which everyday tasks depend, they 
may pay insufficient attention to the role of the environment, and the testing situation 
may be an unrealistic environment, for example, by increasing motivation. Patients may 
also use ameliorative strategies and environmental cues in real life situations. Higginson 
et al (2000) suggest the use of tests designed to be more ecologically valid (such as the 
Test of Everyday Attention and the Rivermead Behavioural Memory Test) and the use 
of subjective measures of cognitive impairment.
1.8.4 Subjective reports of cognitive impairment
An alternative method for assessing extent of cognitive impairment is to gather the self- 
reports of individuals or informants. It has been argued that subjective reports of 
cognitive impairment from patients and their family members provide a rich source of 
additional information regarding cognitive dysfunction (Vinck et al, 1997).
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1.8.4.1 Memory impairment
By far the majority of research on self-reported cognitive impairment in MS has been in 
the domain of memory impairment. There is evidence that MS patients under-report 
memory impairment in comparison to their relatives and to objective tests. Mclntosh- 
Michaelis et al (1991) found that 44% reported memory impairment compared to 54% 
of relatives, indicating a discrepancy between self and other report. Beatty and Monson 
(1991) found that patients underestimated their memory difficulties compared to 
neuropsychological assessment. Taylor (1990) found that test performance correlated 
with relative-reported memory but not self-reported memory.
However, other researchers, such as Randolph, Arnett and Higginson (2001) found that 
patients’ self-reported memory was as accurate as relatives’ reports. Richardson (1996) 
investigated self-reported memory difficulties and found significant correlations 
between self and relative reports and no significant differences between the scores. This 
was found for the most serious problems identified, the frequency of learning and 
memory failures and overall functional level.
A number of questionnaire measures of memory have been developed. Memory 
questionnaires are generally considered to possess good test-retest reliability and 
internal reliability (Wade, 1992). However, the validity of questionnaires is more 
questionable. Sunderland et al (1983) describe two main problems that may invalidate 
patients’ own reports of their memory failures. The first is that the reporting will require 
a memory of that memory failure (i.e. meta-memory) which, by definition, will be 
impaired in those with memory difficulties. The second is that individuals with
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neurological damage may have impaired insight into their cognitive functioning. Taylor 
(1990) found support for the second hypothesis in a sample of MS patients, where the 
discrepancy between patient and relative’s scores was correlated with performance on 
tests of executive dysfunction and not correlated with performance on tests of memory 
functioning. Issues such as mood and social desirability factors are also likely to impact 
on subjective reports.
The Everyday Memory Questionnaire (EMQ) (Sunderland, Harris and Baddeley, 1983) 
is a commonly used self-report measure of memory impairment that has been used in a 
number of MS studies (e.g. Richardson, 1996; Lincoln et al, 2002). Lincoln et al (2002) 
used the EMQ in a neuro-rehabilitation MS population. These patients required 
specialist rehabilitation services and are likely to be more severely physically or 
cognitively disabled than a community MS population.
1.8.4.2 Executive dysfunction
The literature does not contain studies examining self-reported executive dysfunction in 
MS. However, given its prevalence in neuropsychological studies of MS, this is an 
important area for investigation. Self-reported executive dysfunction has, however, been 
investigated in other neurological samples. Research using self-report methodology has 
found that TBI patients commonly underestimate their problems compared to relatives, 
especially more complex skills, such as social abilities (Prigatano et al, 1990). Burgess, 
Alderman, Evans, Emslie and Wilson (1998) examined the relationship between 
neuropsychological assessment and self and relative-reported executive dysfunction in a 
mixed neurological population (predominantly TBI), using the Dysexecutive
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Questionnaire (DEX) (Wilson, Alderman, Burgess, Emslie and Evans, 1996). They 
found that relative-reported problems significantly correlated with neuropsychological 
assessment, whereas self-reported problems did not. They used the discrepancy between 
self and relative-reports as a measure of insight and found that the discrepancy scores 
were significantly related to neuropsychological tests of executive dysfunction. They 
also found that in the predominantly TBI population, self-reported executive 
dysfunction was significantly less than relative-reported executive dysfunction, whereas 
in normal controls, self-reported executive dysfunction was significantly greater than 
relative-reported executive dysfunction. However, they did not investigate the variables 
that might explain these differences. One might expect that a sample of individuals with 
MS would experience less executive dysfunction than TBI patients due to the greater 
variation in lesion site and lower rates of cognitive impairment. One might also expect 
that a sample of MS patients would experience more executive dysfunction than normal 
controls. The DEX questionnaire has only been used with MS patients in one recently 
published study (Lincoln et al, 2002), but not investigated in detail.
1.8.5 Conclusions
Neuropsychological assessment has an invaluable role in assessing cognitive function 
and has been used extensively in MS research. However, there may be some potential 
limitations with the ecological validity of neuropsychological assessment and with the 
neuropsychological assessment of both MS patients and of executive functioning. The 
use of more ecologically based assessments and patient and family reports may provide 
important additional and converging evidence of any cognitive impairment and its 
possible effects. Lincoln and Tinson (1989) conclude, “the ability o f a particular form
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of measurement depends on the purpose o f the assessment. Objective tests are needed to 
identify the nature o f cognitive deficits in patients with neurological damage. Subjective 
assessments are useful for identifying problems which affect daily life and planning 
treatment programmes. ” (p61).
1.9 SUMMARY AND RATIONALE FOR RESEARCH
As discussed, there is evidence that a large number of individuals with MS experience 
some form of cognitive impairment, including executive dysfunction. However, while 
neuropsychological studies have shown deficits in aspects of executive functioning, the 
psychological/behavioural manifestation of any executive dysfunction in MS has not 
been examined. Neuropsychological studies have also found that general cognitive 
impairment has an impact on health status in MS. Neuropsychological assessment is a 
valuable tool for the assessment of cognitive impairment. However, there are 
methodological concerns regarding the ecological validity of neuropsychological 
assessment and its usefulness in predicting health status and psychological variables.
The usefulness of self-reported data on cognitive functioning, particularly in relation to 
problems experienced by patients in everyday lives, is now increasingly recognized. 
Valuable information can also be obtained from the discrepancies between relatives’ 
and patients’ reports of cognitive impairment. However, research is limited, especially 
within MS populations. Stenager et al (1990) highlight the paucity of investigations into 
MS patients’ subjective reports of cognitive impairment. Some research has been 
conducted, but this has concentrated solely on memory impairment. While the role of
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self-report data in executive dysfunction has been examined in TBI populations, it has 
not been examined within MS populations. The DEX questionnaire has been developed 
as a measure of executive dysfunction in a predominantly TBI population, but the 
properties have not been assessed in an MS population. Research has also only briefly 
examined the usefulness of self-reported memory impairment in the prediction of health 
status in MS and has not yet examined the usefulness of self-reported executive 
dysfunction in MS. Research has also not examined the relationship between self- 
reported cognitive impairment and mood in MS.
This study, therefore, proposes to investigate the prevalence and pattern of self-reported 
executive dysfunction in a sample of MS patients and to conduct preliminary 
investigations of the properties of the DEX questionnaire in an MS population. The 
study also proposes to examine the relationship between these variables and mood and 
health status. This may have important implications for predicting patients’ health status 
and psychological distress.
1.10 RESEARCH QUESTIONS AND HYPOTHESES
1. In a community sample of MS patients is the frequency and pattern of 
anxiety and depression significantly different from a normal healthy 
population?
Hypothesis 1.1
i) There will be significantly higher levels of anxiety and ii) depression compared to a 
normal healthy population.
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2. In a community sample of MS patients:
• Is the frequency and pattern of self and relative-reported executive 
dysfunction significantly different from a predominantly TBI population and 
normal controls?
• Is the frequency and pattern of reduced insight significantly different from a 
predominantly TBI population and normal controls?
• Is the frequency and pattern of self and relative-reported memory 
impairment significantly different from a neuro-rehabilitation MS 
population?
Hypothesis 2.1
i) Self-reported executive dysfunction will be significantly lower than that reported in a 
predominantly TBI population and ii) significantly higher than that reported in normal 
populations; iii) relative-reported executive dysfunction will be significantly lower than 
that reported in a predominantly TBI population and iv) significantly higher than that 
reported in normal populations.
Hypothesis 2.2
The discrepancy between self and relative-reported executive dysfunction will be 
significantly different from that found in i) a predominantly TBI population and ii) 
normal controls.
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Hypothesis 2.3
i) Self-reported memory impairment and ii) relative-reported memory impairment will 
be significantly lower than that reported in a neuro-rehabilitation MS population.
3. Does self-reported cognitive impairment predict health status and mood in a 
community sample of MS patients?
Hypothesis 3.1
Subjective reports of executive dysfunction and subjective reports of memory 
impairment will account for a significant proportion of the variance in health status 
(employment status, social functioning and physical role limitations).
Hypothesis 3.2
Subjective reports of executive dysfunction and subjective reports of memory 
impairment will account for a significant proportion of the variance in mood (anxiety 
and depression).
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2. METHOD
2.1 DESIGN
The study was an exploratory survey in which both quantitative and qualitative data
were collected. The design was two-staged, involving:
1. A cross-sectional postal survey of self-reported cognitive difficulties, mood and 
health status in individuals with MS attending neurology clinics in Aylesbury 
and Milton Keynes.
2. A cross-sectional postal survey of the cognitive difficulties of individuals with




Patients were selected from the NHS clinical registers of three consultant neurologists in
two geographical areas (Aylesbury and Milton Keynes).
Inclusion criteria were:
• Individuals with a definite diagnosis of MS, including those who fulfilled the criteria 
of “clinically definite MS” (Poser et al, 1983) and those who fulfilled the new 
criteria of “MS” (McDonald et al, 2001). Individuals fulfilling the old criteria of 
“probable MS” were excluded to increase comparability with the new criteria.
• Individuals who had attended an NHS clinic of one of the neurologists involved.
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• Individuals aged over 16 years old.
Exclusion criteria were:
• Where a clinician involved considered that the individual’s participation in the 
research would be clinically inappropriate.
• Where a clinician involved informed the researcher about a co-morbid psychiatric 
condition.
• Individuals attending the neurology clinics as a private patient.
• Individuals under 16 years old.
2.2.2 Relatives2 3
Patients were invited to name a relative or friend who knew them well. These 




The questionnaire contained questions to gather information on disease variables, such 
as type of MS, duration of illness, demographics and employment status.
2 The term “patients” is used to refer to individuals with MS.
3 The term “relatives” is used to describe the relative, friend or other identified by the patient as knowing 
them well.
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2.3.1.2 The Everyday Memory Questionnaire (EMQ) (Sunderland et al, 1983)
This is a questionnaire to measure self-reported memory difficulties. The EMQ 
comprises 28 questions on aspects of individuals’ everyday memory. Individuals rate 
their answers on a five-point scale, ranging from “once or less in the last month” to 
“once or more in a day”. Scores are summed to give a total score, used as a measure of 
the general extent of everyday memory impairment. The EMQ has been used in a 
number of previous studies using TBI patients (Sunderland et al, 1983), stroke patients 
(Lincoln and Tinson, 1989) and MS patients (Richardson, 1996). For this study the 
original data from a neuro-rehabilitation sample of MS patients (Lincoln et al, 2002) 
was available for comparison.
The psychometric properties of the EMQ have been found to be variable. In a TBI 
sample, Sunderland et al (1983) found poor correlations between self and other reported 
memory impairment and poor correlations between self-reported memory impairment 
and objective test scores, although they found significant correlations between relative’s 
responses and scores on six out of fourteen objective tests. However, Richardson (1996) 
found a high degree of correlation between patient and relative’s reported memory 
difficulties in a sample of MS patients. Lincoln and Tinson (1989) also found self- 
reports to be consistent with relatives’ reports and found significant correlations with an 
objective measure (the Rivermead Behavioural Memory Test). Wade (1992) concludes 
that, overall, the EMQ has acceptable validity and reliability as a measure of subjective 
everyday memory difficulties. Although the psychometric properties of the measure are 
questionable, there are limited other measures available and the EMQ has been widely 
used.
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23.1.3 Hospital Anxiety and Depression Scales (HADS) (Zigmond and Snaith, 1983) 
This is a self-completion measure of subjective symptoms of depression and anxiety 
over the past week. It consists of 14 items, each on a four-point scale, divided into two 
sub-scales (anxiety and depression). A higher score indicates a greater degree of 
distress. The questionnaire was designed to measure anxiety and depression in 
individuals with medical problems and, therefore, excludes items related to both 
emotional and physical disorders (e.g. dizziness). The HADS has been found to have 
acceptable validity, correlating well with psychiatric assessment (0.70 for depression 
and 0.74 for anxiety) (Zigmond and Snaith, 1983), and also correlating well with other 
measures of depression and anxiety (0.76 to 0.77) (Aylard, Gooding, McKenna and 
Snaith, 1987). It has been found to be easily understood and acceptable to patients 
(Bowling, 1998) and has been used extensively in previous research. Normative data are 
available for a non-clinical sample of 1792 adults (Crawford, Henry, Crombie and 
Taylor, 2001). Zigmond and Snaith (1983) recommend the following classification: 0-7 
(normal), 8-10 (mild), 11-15 (moderate), 16+ (severe). In the present study, a score of 
11+ is used as the cut-off for “caseness”, as advocated by Crawford et al (2001). This 
identifies individuals with moderate/severe anxiety or depression.
2.3.1.4 The Dysexecutive Questionnaire (DEX) (Wilson et al, 1996)
This is a questionnaire measure of executive dysfunction, and forms a part of the 
Behavioural Assessment of the Dysexecutive Syndrome. The questionnaire covers four 
areas of likely change (emotion/personality, motivation, behaviour and cognition), based 
on Stuss and Benson’s (1984) model of executive functioning. The questionnaire
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contains 20 items with five-point scales from 0 (never) to 4 (very often). Item scores are 
totalled, with a higher score indicating greater executive dysfunction. Correlation 
coefficients show good internal reliability between the items (Burgess et al, 1998) and 
factor analysis revealed five underlying factors: Inhibition, Intentionality, Executive 
Memory, Positive Affect and Negative Affect. Burgess et al (1998) found that relatives’ 
scores and the discrepancy between patient and relatives’ scores were related to tests of 
executive dysfunction, providing support for its validity as a measure of executive 
dysfunction. Normative data are available for 92 patients from a mixed neurological 
(predominantly TBI) population4. The original data were also available for 82 MS 
patients from a neuro-rehabilitation sample (Lincoln et al, 2002).
23.1.5 Short Form 36 (SF-36) (Ware, Snow, Kosinski and Gandek, 1993)
This is a self-completion measure of general health status/quality of life. The SF-36 
contains 36 items which measure health status across 8 dimensions: physical 
functioning, social functioning, role limitations due to physical problems, role 
limitations due to emotional problems, mental health, energy/vitality, pain and general 
health perception. There is also a single item about perceptions of health changes over 
the past 12 months. The questionnaire contains a number of response formats, including 
yes/no responses, five-point scales and six-point scales. Item scores for each of the 
dimensions are transformed into a scale from 0 (poor health) to 100 (good health). The 
SF-36 has been found to have higher sensitivity than other measures of health status 
(Brazier et al, 1992), and good responsiveness to change (Garratt, Ruta and Abdalla,
4 A mixed neurological population comprising 59% TBI, 13% dementia, 8.5% cerebrovascular accidents, 
6.5% encephalitis and 13% miscellaneous. Described as predominantly TBI throughout the text.
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1993). Brazier et al (1992) report good internal reliability (0.60 to 0.81) and Ware et al 
(1993) report acceptable test-retest reliability (0.43 to 0.90). Ware et al (1993) report 
significant and consistent associations between the scale scores and work ability, 
utilization of care and various mental health criteria. UK normative data are available 
from a community sample (Jenkinson, Coulter and Wright, 1993).
Vickrey, Hays, Harooni, Myers and Ellison (1995) have supplemented the SF-36 with 
18 additional items specifically for MS groups, relating to health distress (4 items), 
sexual function (4 items), satisfaction with sexual function (1 item), overall quality of 
life (2 items), cognitive function (4 items), energy (1 item), pain (1 item) and social 
function (1 item) to produce the Multiple Sclerosis Quality of Life Instrument (MSQOL- 
54). In the current study the SF-36 was chosen because of its wide use in research, its 
good psychometric properties and the availability of normative data. Elements of the 
MSQOL-54 were added to the SF-36. These included the extra question on the energy 
scale, the cognitive function scale and the overall quality of life scale. However the 
MSQOL-54 was not used in its entirety, because of its limited use in previous research 
and to reduce the length of the overall questionnaire.
2.3.1.6 Additional qualitative data
A space was included in the questionnaire for individuals to add any additional 
comments.
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2.3.2 Piloting the patient questionnaire
Four patients attending a support group at a local rehabilitation service piloted the 
questionnaires. They completed the questionnaires and provided feedback over the 
telephone, providing an opportunity for discussion of any difficulties. The piloted 
questionnaires originally included the Cognitive Failures Questionnaire (Broadbent, 
Cooper, Fitzgerald, and Parkes, 1982) as a measure of general self-reported cognitive 
difficulties. However, feedback indicated that this made the total questionnaire battery 
too lengthy, so this measure was removed from the final battery. The approximate time 
for completing the final battery was 30 minutes.
2.3.3 Relatives’ questionnaire
The following measures were used:
• The DEX questionnaire for other completion. This allows a comparison to be made 
between self and other responses, providing a measure of patients’ insight into 
executive dysfunction.
• The EMQ for other completion. This allows a comparison to be made between self 
and other responses, providing a measure of insight into memory difficulties.
• Additional questions regarding demographics.
A space for additional qualitative comments.
2.4 ETHICAL ISSUES
Ethical approval was granted from the Aylesbury Vale Local Research Ethics 
Committee and from the Milton Keynes Local Research Ethics Committee following
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minor amendments. Copies of letters confirming ethical approval are included in 
Appendix A.
The questionnaires were identified with a personal number to link them to the 
appropriate patient and to preserve confidentiality. The information sheet contained 
sources of support for participants should any issues be raised and included a telephone 
number should they wish to contact the researcher. If a completed questionnaire 
contained data raising concern for the welfare of that individual (for example, suicidal 
ideation), the researcher would discuss this with their supervisors and take appropriate 
action.
2.5 PROCEDURE
There were slight differences in procedure between regions based on the resources 
available and preference of the clinicians involved. In the Aylesbury sample, no 
electronic database existed for the MS patients. Therefore, the consultant neurologist 
gave the researcher a list of all patients with MS and access to the patients’ neurology 
files. The neurologist reviewed the list for any inappropriate participants. The files were 
examined to obtain demographic information, MS information (whether they had 
clinically definite MS, subtype, date of diagnosis) and GP details, and the researcher 
inputted this information to a database. For some patients, the neurology files were 
unobtainable and the patient’s medical notes were accessed for information. In the 
Milton Keynes sample, the researcher was given a printout of the demographic 
information of all individuals with clinically definite MS. The MS Clinical Specialist 
reviewed the list for appropriate participants and the researcher inputted details to a
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database. From these databases, personalised letters were sent to all individuals 
fulfilling the criteria, and an information sheet, a consent form and the questionnaires 
were enclosed. These are shown in Appendix B.
Participants were invited to complete the questionnaires and return them to the 
researcher. Participants were advised that they could ask for help completing the 
questionnaires from a family member, or could contact the researcher and complete the 
questionnaires over the telephone. Individuals who wished to participate were asked to 
return their completed questionnaires along with the signed consent form. If they did not 
want to participate they were asked to return the blank questionnaires. A reminder letter 
was sent (see Appendix C) if individuals did not respond after three weeks.
They were also asked to supply the name and address of someone who knew them well, 
who they consented to being contacted to complete the relatives’ survey. If patients had 
provided details of a relative, personalised letters were sent to that person with an 
information sheet, a consent form and the questionnaires (see Appendix D). A reminder 
letter was sent (see Appendix E) if individuals had not responded after three weeks. 
However, due to delay in access to the Milton Keynes sample, time constraints did not 
allow for reminder letters to be sent for this sample.
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• the demographics of the two samples;
• the properties of the DEX questionnaire;
• the investigation of proposed hypotheses, and
• the investigation of additional exploratory hypotheses.
3.2 PREPARATION FOR DATA ANALYSIS
Statistical testing was guided by whether the data fulfilled the assumptions for 
parametric analysis, and following statistical advice from a consultant statistician. 
Kolmogorov-Smimov tests and histograms were used to test for normal distribution of 
the data. Levene’s test was used to assess homogeneity of variance. In cases where the 
assumptions were not met, non-parametric tests were used. If no suitable non-parametric 
alternatives were available, data were appropriately transformed. Where existing 
literature allowed a directional hypothesis (hypotheses 1.1, 2.1 and 2.3), one-tailed 
probabilities were used. For non-directional hypotheses (2.2, 3.1, 3.2 and additional 
exploratory hypotheses), two-tailed probabilities were used.
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3.3 DEMOGRAPHIC DATA
3.3.1 Sample characteristics: patients
3.3.1.1 Sample size
In the Aylesbury sample, 109 patients fulfilled the inclusion criteria and were invited to 
participate. Sixty-seven completed the questionnaire, 11 returned a blank questionnaire, 
3 were unobtainable at the known address and 28 did not respond. This was an overall 
response rate of 74.3% and a completed response rate of 61.5%. In the Milton Keynes 
sample, 154 met the inclusion criteria and were invited to participate. Eight-two 
completed the questionnaire, 17 returned a blank questionnaire, 3 were unobtainable at 
the known address and 53 did not respond. Two were excluded from the analysis 
because their questionnaire responses were obviously from their relative’s viewpoint 
and not their own. This was an overall response rate of 64.6% and a completed response 
rate of 53.3%. For the total sample there was an overall response rate of 67.3% and a 
completed response rate of 56.7%. This was a good response rate, compared to an 
expected response rate from a postal survey of approximately 30% (Goyder, 1985) and 
particularly good for a neurological population. The total sample size for which the 
results are presented was 147.
3.3.1.2 Age
The age range of the participants was 20 to 73 years, with a mean of 47.4 (standard 
deviation (SD) =10.8). A Mann-Whitney test revealed no significant difference in age 
between regions. Previous research on MS patients has found similar ages, such as Rao 
et al (1991a) who found a mean age of 46.3 (SD=11.0).
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3.3.1.3 Gender
Of the 147 participants, 41 were male and 106 were female (a ratio of 1:2.6). There were 
slightly more females than expected compared to known prevalence rates (1:1.5-2, 
Sibley, 1990). However, this did not represent a significant difference as tested by chi- 
square.
3.3.1.4 Marital status
Of the 147 participants, 102 were married, 18 were divorced, 12 were single, 8 were co­
habiting, 5 were widowed and 2 were engaged.
3.3.1.5 Occupation and qualifications
Sixty-three (57.1%) participants were not working and 61 (72.6%) of these participants 
reported a change in their working situation because of MS. Fifty-seven (55.9%) 
reported having taken early retirement, 22 (21.6%) reported having changed tasks within 
the job, 22 (21.6%) reported having reduced working hours, 22 (21.6%) reported having 
taken sick leave and 9 (8.8%) reported having gone part-time.
3.3.1.6 MS subtype
Seventy-five (51.0%) participants knew their MS subtype, 25 (17.0%) did not know and 
47 (32.0%) were unsure. Of the 75 who knew their subtype, 43 (47.3%) reported having 
relapsing-remitting MS, 23 (25.3%) reported having secondary-progressive MS, 22 
(24.2%) reported having primary-progressive MS and 3 (2%) reported having benign 
MS. There were differences in incidence of the different subtypes between regions. In 
the Milton Keynes sample there were fewer individuals with relapsing-remitting MS and
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more with secondary-progressive MS. The percentages of each subtype are illustrated in 
Table 1 with comparative normative data. Chi-square analyses revealed that the 
frequency of each subtype in the current total sample was significantly different from 
that reported in the general population (%2=13.53, df=3, p=0.004), with fewer patients 
with benign MS and more with primary progressive MS. The current sample was also 
significantly different from that found in a neuro-rehabilitation population (Foong et al, 
1997) (x2=28.69, df=2, pO.OOOl), comprising more patients with primary-progressive 
MS and fewer patients with relapsing-remitting MS.





sam ple % 
(n=34)
M ilton Keynes 




(BSR M , 1993)
Neuro-rehab  
population % 
(Foong e t al, 
1 9 9 7 )(n=42)
Relapsing-
remitting
47.3 53.8 42.3 40 66.7
Primary-
progressive
24.2 20.5 26.9 10-15 7
Secondary-
progressive
25.3 17.9 30.8 30 23.8
Benign 3.3 7.7 0 10-15 2.4
To provide a rudimentary validation of patients’ self-reported subtype, clinician ratings 
were gathered from the neurology files for a sub-sample of 20 random Aylesbury 
patients. A cross-tabulation was calculated on these values. There was 70% agreement 
between ratings. The Kappa value was .60, p<0.001, indicating a significant, moderate- 
to-substantial relationship (Landis and Koch, 1977) between patient-reported subtype 
and subtype in the neurology file.
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3.3.1.7 Disease duration
The time since diagnosis reported by participants ranged from 6 months to 43 years, 
with a mean of 10.19 (SD=8.82) years. This is similar to the disease duration reported 
by Rao et al (1991), who found a range of 1-43 years, with a mean 9.5 (SD=9.0). The 
median time since diagnosis was 7.5 years, and the sample was positively skewed.
A Mann-Whitney test indicated a significantly longer time since diagnosis in the Milton 
Keynes sample than the Aylesbury sample (U=2081.0, p=0.026). A Kruskal Wallis test 
also indicated significant differences between each subgroup on time since diagnosis 
(X2=15.01, df=3, p=0.002). The mean ranks indicated differences in the expected 
direction (secondary-progressive (53.79), primary-progressive (40.44), relapsing- 
remitting (31.36) and benign (18.83). This provided support for the hypothesis that the 
greater number of individuals who had progressed on to secondary-progressive MS in 
the Milton Keynes sample was related to a significantly greater time since diagnosis in 
this group.
3.3.1.8 Relapses
One hundred and seven (72.3%) of the sample reported having relapses as a part of their 
MS and 36 (24.3%) reported currently experiencing a relapse.
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3.2.1.9 Other illnesses
Forty-eight (32.4%) reported experiencing other illnesses. These are shown in Table 2.
Table 2: Illnesses reported by the patients














Carpal tunnel syndrome 1
Angina 1
Amputation 1
3.3.2 Sample characteristics: relatives
3.3.2.1 Sample size
In the Aylesbury sample, 59 patients provided details of a relative to contact. Of these, 
44 returned completed questionnaires and 3 returned blank questionnaires. This was an 
overall response rate of 79.7% and a completed response rate of 74.6%. In the Milton 
Keynes sample, 74 patients provided details of a relative. Of these, 39 returned 
completed questionnaires and none returned blank questionnaires. This was a completed 
response rate of 52.7%. For the total sample of relatives there was a completed response 
rate of 62.4%. This was also a good response rate for a postal survey (Goyder, 1985). 
One relative’s questionnaire was omitted because it related to an omitted patient
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questionnaire. The total sample size of relatives for which the results are presented is 
82.
3.3.2.2 Age
Relative’s ages ranged from 20-84 (4 missing), with a mean of 46.6 (SD=13.28) years.
3.3.2.3 Gender
There were 45 (56.3%) females and 35 (43.8%) males (2 missing).
3.3.2.4 Relationship
Twenty-seven (32.9%) relatives described their relationship as husband, 16 (19.5%) as 
wife, 5 (6.09%) as partner, 7 (8.54%) as mother, 6 (7.31%) as sister, 2 (2.44%) as son, 6 
(7.31%) as friend, 2 (2.44%) as carer and 2 (2.44%) as other. Fifty-four (65.9%) lived 
with the patients and 28 (34.1%) did not. Sixty-four relatives (79%) saw the patient 
daily, 15 (18.5%) saw them once a week and 2 (2.5%) saw them less than once a month. 
The relatives had known the patients for a mean of 24.05 years (SD=12.94) with a range 
of 1-63 years and 88.9 % of the relatives had known them before they were diagnosed 
with MS.
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3.4 PROPERTIES OF THE DYSEXECUTIVE QUESTIONNAIRE (DEX)
Data were examined to indicate the properties of the DEX questionnaire in this sample.
3.4.1 Pattern of responses
The pattern of responses for the patients and relatives is shown in Table 3.
Table 3: Responses on the DEX
PATIENT REPSONSES RELATIVE RESPONSES
Item Mean (sd) Median Range No.
missing
Mean (sd) Median Range No.
missing
1 1.18(1.07) 1 0-4 2 1.08(1.09) 1 0-4 2
2 1.21 (1.03) 1 0-4 2 1.14(1.12) 1 0-4 2
3 .29 (.69) 0 0-3 2 .29 (.77) 0 0-4 2
4 1.14(1.24) 1 0-4 2 1.18(1.28) 1 0-4 2
5 .81 (1.07) 0 0-4 2 .98 (1.30) 0 0-4 2
6 1.03(1.05) 1 0-4 3 1.14(1.08) 1 0-4 2
7 1.02(1.16) 1 0-4 6 1.05 (1.34) 0 0-4 2
8 1.70(1.23) 1 0-4 2 1.79(1.31) 2 0-4 2
9 .76 (.94) .5 0-4 3 .73(1.12) 0 0-4 2
10 1.16(1.25) 1 0-4 2 1.13(1.16) 1 0-4 2
11 1.08(1.30) 1 0-4 2 1.20(1.23) 1 0-4 2
12 1.35 (1.22) 1 0-4 2 1.38 (1.28) 1 0-4 2
13 .71 (.92) 0 0-4 4 .71 (1.07) 0 0-4 2
14 .71 (1.02) 0 0-4 2 .65(1.10) 0 0-4 2
15 1.37(1.27) 1 0-4 2 1.16(1.21) 1 0-4 2
16 1.21 (1.25) 1 0-4 2 1.08(1.28) 1 0-4 2
17 .95 (1.04) 1 0-4 2 .95(1.12) 1 0-4 2
18 1.67(1.28) 1 0-4 1 1.49(1.21) 1 0-4 2
19 1.71 (1.31) 2 0-4 2 1.65 (1.35) 1 0-4 2
20 .97(1.15) 1 0-4 4 .98(1.24) 0 0-4 2
The patient and relative’s responses were very similar. For all except one question, both 
groups used the maximum range, however, the mean and median values were low for all 
items. The highest items scored by patients and relatives were DEX8 (I am lethargic, or 
unenthusiastic about things) and DEX 19 (I have trouble making decisions, or deciding 
what I want to do). The lowest item scored by patients and relatives was DEX3 (I 
sometimes talk about events or details that never actually happened, but I believe did
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happen). DEX7 (I have difficulty realizing the extent of my problems and am unrealistic 
about the future) had a comparatively large number of missing data for the patient 
sample.
3.4.2 Internal reliability
Cronbach’s alpha values were calculated to determine the internal consistency of the 
DEX. The alpha values for the total scales were 0.92 (patient questionnaire) and 0.95 
(relative questionnaire). Individual alpha values if items were deleted ranged from 0.91 
to 0.95. Nunally (1978) suggests that 0.7 is the minimally acceptable level for internal 
consistency. These alpha levels indicate that over 90% of the measured variance is 
reliable, indicating good internal consistency and that no individual items reduce the 
reliability of the scale.
Item-total correlations were also calculated to measure the extent to which each item 
correlated with the total score. These values ranged from 0.42 to 0.75 for the patient 
questionnaire and from 0.35 to 0.81 for the relative questionnaire. Kline (1986) suggests 
that item-total correlations should be above 0.20, therefore, these results show good 
internal consistency for both versions of the questionnaire. There were four questions 
with low coefficients. For the patients’ questionnaire, these were DEX5 (I sometimes 
get over-excited about things), DEX11 (I have difficulty showing emotion), DEX15 (I 
tend to be very restless) and DEX 16 (I find it difficult to stop myself from doing 
something). For the relatives’ questionnaire, it was DEX11.
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3.5 INVESTIGATION OF HYPOTHESES
3.5.1 Hypothesis 1.1
i) There will be significantly higher levels of anxiety and ii) depression compared
to a normal healthy population.
The descriptive statistics from the Hospital Anxiety and Depression Scales (HADS) are
shown in Table 4.
Table 4: Descriptive statistics from the HADS
N Mean SD Range
Anxiety 144 8.55 4.40 0-19
Depression 144 5.91 3.53 0-16
The responses on the anxiety and depression scales were positively skewed. However, 
with a large sample size, it is reasonable to assume a normal distribution for the sample 
mean (Kirkwood, 1988). Therefore, in this instance statistical advice was that a t-test 
was suitable.
i) The mean score on the anxiety scale was 8.58 (SD=4.4) and the mean score
in the normal population was 6.14 (SD=3.76) (Crawford et al, 2001). This represented a 
significant difference (t=6.603, df=144, pO.OOOl, one-tailed). There were 47 
participants (32.4%) scoring above caseness for anxiety, who were above the 88th 
percentile for the normal population.
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ii) The mean score on the depression scale was 5.94 (SD=3.53) and the mean score 
in the normal population was 3.68 (SD=3.07). This represented a significant difference 
(t=7.576, df=143, pO.OOOl, one-tailed). There were 18 participants (12.5%) scoring 
above caseness for depression, who were above the 96th percentile for the normal 
population.
3.5.2 Hypothesis 2.1
i) Self-reported executive dysfunction will be significantly lower than that reported 
in a predominantly TBI population and ii) significantly higher than that reported 
in normal populations; iii) relative-reported executive dysfunction will be 
significantly lower than that reported in a predominantly TBI population and iv) 
significantly higher than that reported in normal populations.
Table 5 shows the mean values used for these analyses
Table 5: Descriptive data from the DEX for the current and normative samples
Score on D ysexecutive Q uestionnaire (DEX) N M ean SD Range
Self-ratings
Current sample 137 22.01 14.33 0-80
TBI population (Burgess e t a l) 92 27.20 13.96 -
Normal controls (Burgess e t  a l) 216 21.04 9.69 -
Relative-ratings
Relatives scores 80 21.71 16.91 0-71
TBI population (Burgess e t  a ï) 92 33.52 16.15 -
Normal controls (Burgess e t a ï) 216 16.97 11.72 -
i) The responses on the DEX were positively skewed. However, the non­
parametric alternative to the t-test (sign test) requires a median value, which was not
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obtainable for the TBI population. Also, with a large sample size, it is reasonable to 
assume a normal distribution for the sample mean (Kirkwood, 1988). Therefore, in this 
instance statistical advice was that a t-test was suitable. For these analyses, the 
normative data reported by Burgess et al (1998) were used. The mean self-rating on the 
DEX in the study sample was 22.01 (SD=14.33), and the mean self-rating from the 
predominantly TBI sample was 27.20 (SD=13.96). This represented a significant 
difference (t=-4.235, df=136, p<0.0001, one-tailed), providing support for the 
hypothesis that self-reported executive dysfunction will be significantly lower than that 
reported in a predominantly TBI population.
ii) The mean self-rating from a sample of normal controls was 21.04 (SD=9.69). A 
t-test indicated no significant difference, indicating that self-rated DEX scores from the 
current sample of MS patients were not significantly different from normal controls. 
This did not provide support for the hypothesis that self-reported executive dysfunction 
will be significantly higher than that reported in normal controls.
iii) The relatives’ ratings on the DEX questionnaire were also positively skewed, 
however the t-test was deemed suitable for the same reasons given above. The mean 
other-rating was 21.71 (SD=16.91) and the mean other-rating from the predominantly 
TBI population was 33.52 (SD=16.15). This represented a significant difference (t=- 
6.245, df=79, pO.OOOl, one-tailed), providing support for the hypothesis that relative- 
reported executive dysfunction will be significantly lower than that reported in a 
predominantly TBI population.
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iv) The mean other-rating on the DEX was 21.71 (SD=16.91) and the mean other- 
rating from a sample of normal controls was 16.97 (SD=11.72). This represented a 
significant difference (t=2.508, df=79, p=0.007, one-tailed), providing support for the 
hypothesis that relative-reported executive dysfunction will be significantly higher than 
that reported in normal controls.
3.5.3 Hypothesis 2.2
The discrepancy between self and relative-reported executive dysfunction will be 
significantly different from that found in i) a predominantly TBI population and 
ii) normal controls.
The discrepancy score was calculated by subtracting the patient score from the relative 
score, following Burgess et al (1998). Table 6 shows the mean values used for the 
analysis.
Table 6: Discrepancy scores on the DEX for the current and normative samples
I D iscrepancy between relative and patient scores N M ean SD Range
I Current sample 75 -1.71 13.76 -33 - +47
I TBI population (Burgess e t a l) 92 6.32 - -
1 Normal controls (Burgess e t a l) 216 -4.07 - : 1
i) The mean DEX discrepancy score was -1.71 (SD=13.76) with a range o f -33 to 
47 and the mean discrepancy score in a predominantly TBI population was 6.32 
(SD=unavailable). A one-sample t-test revealed a significant difference (t=2.903, df=74, 
p=0.005, two-tailed). The discrepancy between scores was significantly less than that 
reported in a predominantly TBI population.
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ii) The mean DEX discrepancy score in comparative normal controls was -4.07 
(SD=unavailable). A one-sample t-test revealed a significant difference (t=-3.636, 
df=74, p=0.0001, two-tailed). The discrepancy between scores in the sample was 
significantly higher than that found in normal controls.
A Wilcoxon test indicated no significant difference between paired self and relative 
reports of executive dysfunction in the current sample. In a predominantly TBI 
population, relatives reported significantly more executive dysfunction than the patients 
reported of themselves, leading to a positive discrepancy (relative minus patient score). 
In normal controls, relatives reported significantly less executive dysfunction than the 
controls did of themselves, leading to a negative discrepancy. In the current sample, 
there was no significant discrepancy in either direction, indicating that the MS 
population lay in between the TBI population and normal controls. This is indicated in 
Figure 2.
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3.5.4 Hypothesis 2.3
i) Self-reported memory impairment and ii) relative-reported memory impairment 
will be significantly lower than that reported in a neuro-rehabilitation MS 
population.
Table 7 shows the data used for these analyses.
Table 7: Descriptive data for EMQ from current and normative samples
Sample N Mean SD Range 1
Current patient scores 138 22.25 21.75 0-62
Neuro-rehabilitation MS sample patient scores (Lincoln e t  a t) 76 26.11 24.02 0-96
Current relative scores 74 19.54 22.11 0-110
Neuro-rehabilitation MS sample relative scores (Lincoln e t a t) 64 21.06 23.57 0-104
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i) Self-reported EMQ scores were also positively skewed, which, following 
statistical advice, was rectified using a square root transformation. This produced a 
normal distribution (z=.853, p=0.461). For these analyses, the original data reported by 
Lincoln et al (2002) were used, allowing these data to be transformed using square root 
for comparability and a one-sample t-test to be conducted on the mean value. The mean 
self-reported EMQ score for the study sample was 22.25 (SD=21.75), transformed to a 
mean of 4.04 (SD=2.44). The mean self-reported EMQ score from the neuro­
rehabilitation MS sample was 26.11 (SD=24.02) transformed to a mean of 4.55 
(SD=2.35). This represented a significant difference (t—2.439, df=T37, p=0.008, one- 
tailed), providing support for the hypothesis that self-reported memory impairment will 
be lower than in a neuro-rehabilitation MS sample.
ii) Relative-reported EMQ scores were also positively skewed, which was rectified 
using a square root transformation. This produced a normal distribution (z=.844, 
p=0.474). The original data reported by Lincoln et al (2001) was also transformed using 
square root and a one-sample t-test was conducted on the mean value. The mean 
relative-rating for the study sample was 19.54 (SD=22.11), transformed to a mean of 
3.62 (SD=4.55) and the mean relative-rating in a neuro-rehabilitation MS sample was 
21.06 (SD=23.57), transformed to a mean of 3.71 (SD=2.72). No significant difference 
was found.
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3.5.5 Section summary
• The current sample reported higher levels of depression and anxiety than the 
normal population.
• MS patients reported themselves as experiencing lower levels of executive 
dysfunction than the predominantly TBI population, but the same levels as 
normal controls. Their relatives reported lower levels of executive dysfunction 
than the predominantly TBI population, but more than normal controls.
• There was no significant discrepancy between patient and relatives reports of 
executive dysfunction. However, the extent of the discrepancy was less than that 
found in the predominantly TBI population and more than that found in normal 
controls.
• The patients reported lower levels of memory impairment than that reported in a 
neuro-rehabilitation MS sample. Their relatives reported the same level of 
memory impairment as in a neuro-rehabilitation MS sample.
3.6 PREDICTION OF HEALTH STATUS AND MOOD
3.6.1 Hypothesis 3.1
Subjective reports of executive dysfunction and subjective reports of memory 
impairment will account for a significant proportion of the variance in health 
status.
Three measures of health status were used (physical role limitations, employment status 
and social functioning); therefore, three separate analyses were conducted. Missing data 
were dealt with by listwise deletion. The number of valid cases was 44, and the ratio of
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cases to independent variables was satisfied according to Tabachnik and Fidell (1989). 
Correlations between applicable variables were examined. Several correlations were 
significant and so regression analysis was deemed appropriate. Also, none of the 
correlation coefficients were more than 0.8, indicating low risk of multicollinearity. In 
each analysis, the tolerance values were also examined to assess risk of 
multicollinearity. The distribution of residuals was examined for normality. Given the 
exploratory nature of the hypothesis, all variables were entered together and stepwise 
regressions were requested, to provide the “best fit” model.
3.6.1.1 Prediction o f physical role limitations
For this analysis the residuals were not normally distributed, therefore regression was 
not appropriate. However, examination of the Spearman’s p  correlation coefficients 
indicated that those with poorer physical role limitations had higher levels of self- 
reported memory impairment (/t=-.234, p=0.006, n=134) and executive dysfunction (p=- 
.173, p=0.047, n=133) and higher levels of relative-reported memory impairment {p=- 
.299, p=0.01 l,n=72).
3.6.1.2 Prediction o f social functioning
Independent variables were age and gender, duration of disease and type of MS 
(dummy-coded5), physical functioning, anxiety and depression, self-reported EMQ and 
DEX scores, relative-reported EMQ and DEX scores and discrepancy between self and 
other EMQ and DEX scores. The regression equation was significant (F(i,42)=40.19).
5 Dummy coding allowed the subtype variable with 3 categories (RR-MS, PP-MS and SP-MS) to be 
converted to 2 dichotomous variables. Subtype I indicated PP-MS or not, Subtype II indicated SP-MS or 
not and RR-MS was, therefore, indicated by a zero on either variable.
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Depression was the only predictor of social functioning (t—6.339, pO.OOOl), 
explaining 47.7% of the variance (R2=.477, df=l,42, pO.OOOl). See Table 8 for the 
regression equation.
Table 8: Regression Equation: social functioning
Adjusted
R2
U nstandardized coefficients t P
Beta Standard Error
I (Constant) 98.705 5.444 18.130 .000
1 Depression .477 -5.080 .801 -6.339 .000
Since subtype was not predictive and reduced the sample size, the analysis was repeated 
with a larger sample size by excluding subtype. The regression equation was significant 
(F(i,67)=83.057, pO.OOOl). Depression was the only predictor of social functioning (t=- 
9.114, df=l,67, pO.OOOl), predicting 55.7% of the variance (R2=.557, df=l,67, 
pO.OOOl).
3.6.1.3 Prediction o f employment status
Since the variable “employment status” was dichotomous, a logistic regression was 
conducted using the same independent variables. The overall model was significant 
(X2=30.10, df=12, p=0.003). The two significant coefficients were physical functioning 
(Wald=3.989, p=0.046) and subtype I (Wald=5.164, p=0.023). MS patients with 
primary-progressive MS and poorer physical functioning were less likely to be working. 
Conversely, those with relapsing-remitting MS and better physical functioning were 
more likely to be working. The model predicted 84.1% of the responses correctly. The 
significant results of this regression are presented in Table 9.
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Table 9: Logistic regression: employment status
B W ald P
Subtype I -4.253 5.164 .023*
Physical functioning .072 3.989 .046*
Constant -7.621 3.848 .050
3.6.2 Hypothesis 3.2: Subjective reports of executive dysfunction and subjective 
reports of memory impairment will account for a significant proportion of the 
variance in mood.
3.6.1.4 Prediction o f depression
The same independent variables were entered. The regression equation was significant 
(F(1;4 0)=l0.558, pO.OOOl). Altogether, 40.0% of the variance (R2=.400, df=l,40, 
p<0.0001) was predicted by patient DEX score, DEX discrepancy score and age. Patient 
DEX score (t=5.241, p<0.0001) was the strongest predictor of depression, followed by 
DEX discrepancy score (t=-2.244, p<0.030) and age (t=2.052, p=0.047). Table 10 shows 
the regression equation.
Table 10: Regression equation: depression
Adjusted
R2
U nstandardized coefficients t P
Beta Standard Error
(Constant) - -1.204 2.173 -.554 .583
Patient DEX .300 .121 .031 3.918 .000
DEX discrepancy .353 -8.045E-02 .036 -2.244 .030
Patient age .400 8.601E-02 .042 2.052 .047
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Since subtype was not a significant predictor, the analysis was repeated with a larger 
sample size by excluding subtype data. The regression equation was significant 
(F(i,67)=30.554, pO.OOOl). Altogether, 30.3% of the variance (R2=.303, df=l,67, 
p<0.0001) was predicted by patient DEX score (t=5.528, pO.OOOl).
3.6.1.5 Prediction o f anxiety
Using the same independent variables, the regression equation was significant 
(F(i,42)=30.450, pO.OOOl). Altogether, 57.8% of the variance (R2=.578, df=l,42, 
pO.OOOl) was predicted by patient total DEX score and subtype I. Patient DEX score 
(t=7.340, pO.OOOl) was the strongest predictor of anxiety, followed by the subtype I 
(t=-2.382, p=0.022). Table 11 shows regression equation.
Table 11: Regression equation: anxiety
Adjusted
R2
Unstandardized coefficients t P
Beta Standard Error
(Constant) 4.143 .803 5.158 .000
Patient DEX .531 .209 .028 7.340 .000
Subtype I .578 -2.398 1.007 -2.382 .022
Given the dummy-coded nature of the variables these results could suggest either that 
those with primary-progressive MS report lower levels of anxiety or that individuals 
with relap sing-remitting MS report greater levels of anxiety. Kruskall-Wallis analyses 
indicated that individuals with relapsing-remitting MS report significantly higher levels 
of anxiety than those with primary-progressive (7.217, df=l, p=0.007) and secondary- 
progressive MS (7.226, df=2, p=0.027). The conclusion was that a higher DEX score 
and relapsing-remitting-MS was predictive of higher levels of anxiety.
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3.7 COMPARISON OF TWO GROUPS: UNDER-REPORTERS AND OVER­
REPORTERS
3.7.1 Creation of two sub-groups
There was a concern that examination of the mean values of the group may be masking 
significant relationships between variables. It was felt appropriate to explore for the 
existence of separate subgroups within the overall sample. This was attempted by 
examination of the discrepancy between patient and relative DEX scores. Some 
individuals reported few executive problems compared to their relatives, some reported 
more executive problems compared to their relatives and others reported the same level. 
The discrepancy values were interesting because of the differences seen in TBI (high 
negative discrepancy) and the differences seen in a normal population (high positive 
discrepancy). A clearer indication of discrepancies in DEX scores is indicated in the 
scatter-plot in Figure 3. There were some individuals who had close agreement with 
their relatives. This would be indicated by a discrepancy score of approximately 0, and a 
range of -5 to 5 was chosen to indicate close agreement (indicated between the parallel 
lines on the graph). Those above and below this range were divided into two groups, 
producing a group of patients who over-report executive dysfunction (N=25) and a 
group who under-report executive dysfunction (N=18). These two groups were then 
used for analyses to investigate possible differences between those who over-report and 
under-report.
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Figure 3: Scatter-plot showing discrepancies between self and relative-reported 
executive dysfunction and division into three groups
Individuals who under-report executive dysfunction
Individuals who over-report executive dysfunction
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3.7.2 Differences between groups
Descriptive statistics for the two groups were examined and appropriate analyses were 
conducted. These findings are indicated in table 12.






Analysis o f  difference 
between groups
M ean SD M ean SD
Age* 45.44 8.97 51.50 10.07 t=-2.076, df=41, 
p=0.044
Disease duration 8.68 8.11 10.17 8.38 ln.s
Anxiety 9.60 3.85 7.56 3.71 n.s.
Depression 7.16 3.73 6.22 3.99 n.s
Patient EMQ 26.08 17.93 21.83 22.18 n.s
Relatives EMQ** 12.35 12.85 36.73 32.05 U = 72.0, p=0.003
EMQ discrepancy** -13.09 16.62 13.47 18.86 t=-4.57, df=36, 
pO.OOOl
H ealth status scales
Physical functioning 29.4 30.70 30.56 32.44 n.s
Physical role limitations 33.33 37.35 27.78 38.44 n.s
Mental role limitations 62.50 37.35 66.67 44.28 n.s
Social function 57.50 27.00 64.58 25.81 n.s
Mental Health 64.00 19.49 72.67 13.11 n.s
Energy/vitality 29.40 18.27 32.65 22.16 n.s
Pain 53.78 31.86 56.79 32.76 n.s
Health perceptions 41.80 25.14 48.53 23.90 n.s
Change in health 34.00 23.80 38.89 23.04 n.s
Quality of life 55.21 17.74 56.94 19.87 n.s
Extended energy/vitality scale 30.08 19.22 34.59 20.73 n.s
Cognitive function 57.20 22.04 69.17 20.67 n.s
C ategorical variables N % N %
Gender (female) 16 64 8 44.4 n.s
Subtype (RR) 11 44.0% 2 11.1% n.s
Subtype (PP) 4 16.0% 4 22.2% n.s
Subtype (SP) 2 8.0% 2 11.1% n.s
Subtype (Benign) 1 4.0% 1 5.6% n.s.
Work status (working) 52.0% 38.9% n.s.
6 Not significant
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Patients who over-report executive difficulties compared to their relatives were 
significantly older and also reported significantly more memory impairment than their 
relatives.
3.7.3 Discriminant function analysis
A discriminant function analysis was conducted to determine which combination of 
variables best discriminated between those who over-report (score of 1) and those who 
under-report (score of 2) executive dysfunction. The following variables were included 
as potential discriminating variables: age, gender, time since diagnosis, MS subtype 
(dummy-coded), relative’s gender, anxiety, depression, patient EMQ, relative EMQ and 
physical functioning. A step-wise analysis was requested using Wilk’s Lambda as the 
criteria for power of separation between groups. Inclusion of the data of MS subtype 
reduced the total sample size to 23, with 16 over-reporters and 7 under-reporters. This 
fulfilled the criteria for minimum sample size (that the number of the smallest group 
should be greater than the number of predictors) (Tabachnik and Fidell, 1989).
The four extracted variables are shown in Table 13. 
Table 13: Discriminant function analysis summary
Step Entered W ilks’ Lambda P
1 Anxiety .791 .028
2 Relative EMQ score .661 .016
3 Patient EMQ score .505 .004
4 Subtype .372 .001
The unstandardised canonical discriminant function coefficients and groups means are 
shown in Table 14.
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Table 14: Unstandardised canonical discriminant function coefficients and group 
means
Coefficient G roup means M ean
Subtype II 1.956
Anxiety -.169 Over-report -.822
Patient EMQ -.048 Under-report 1.878
Relative EMQ .054
(Constant) 1.305
Over-reporters were more likely to have relapsing-remitting MS, report higher levels of 
anxiety, report higher levels of memory impairment and have lower levels of relative- 
reported memory impairment. The discriminant function correctly classified 87.0% of 
cases (see Table 15).
Table 15: Classification of cases into groups
Actual group N Predicted over-reporters Predicted under-reporters
Over-reporters 16 15 1
93.8% 6.2%
Under-reporters 7 2 5
28.6% 71.4%
3.8 QUALITATIVE DATA
The patients and relatives were invited to provide additional comments. Some of these 
comments provide interesting support for a higher rate of distress in the “over-reporters” 
Two “over-reporters” commented, “/ find it difficult to come to terms with feeling that I  
have very little control over how the disease is affecting me”\ and “/  lack confidence 
because I  am not in control o f my physical and mental abilities”. These comments were 
not as apparent in the “under-reporters”.
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Comments covered a number of other topics. Numbers indicate number of comments. 
Patients commented on fatigue (10), pain (7), visual problems (4), mobility problems 
(4), incontinence (3), other sensations (3) and sleep problems (2). Some commented that 
their problems were mostly physical (3) and life very limited (5). Others mentioned 
memory (7), wording finding (2) and concentration (2) difficulties. Patients also 
mentioned emotional difficulties such as irritability (2), frustration (3) and depression 
(3). Patients commented on disease variability (3), relapses (1), and a lack of control 
over the disease (3). Others mentioned a difficulty in adjusting to the disease (3), trying 
to take a positive outlook (5), the importance of support (2) and of faith (1). One patient 
commented on the positive effect of MS on their life.
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4. DISCUSSION
4.1 OVERVIEW
This section begins with a summary of the results, followed by a summary detailing the 
findings of the investigated hypotheses. Methodological issues are discussed and the 
results are interpreted. Implications are discussed for theory and clinical practice, 
recommendations suggested for future research and conclusions drawn from the study.
4.2 SUMMARY OF FINDINGS
4.2.1 Sample characteristics
The gender proportions, age range and disease duration were representative of other 
study populations (e.g. Rao et al, 1991a). The majority of the sample were not working 
and the majority of these reported MS to be the reason. The prevalence of MS subtypes 
was significantly different from that found in community populations and neuro­
rehabilitation populations and also significantly differed between regions. The 
implications of this are discussed later. The majority of informants chosen by the 
patients for the study were family members and 79% saw the patient daily.
4.2.2 Investigation of hypotheses
The findings were as follows:
• The sample reported significantly higher levels of anxiety and depression than 
the normal population.
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• The amount of executive dysfunction reported by patients was lower than in a 
predominantly TBI population and not significantly different from that reported 
by normal controls.
• The amount of executive dysfunction reported by relatives was lower than that 
reported in a predominantly TBI population, but significantly higher than normal 
controls.
• In the group overall, there was no significant difference between patient and 
relatives’ reports of executive dysfunction. However, the amount of discrepancy 
was lower than that found in a predominantly TBI population and higher than 
found in normal controls, indicating a deviation from the normal population.
• The amount of memory impairment reported by patients was lower than in a 
neuro-rehabilitation sample, but the amount reported by relatives was not 
significantly different.
• Individuals with poorer physical role limitations had higher levels of self- 
reported memory impairment and executive dysfunction and higher levels of 
relative-reported memory impairment.
• Depression was the only predictor of social functioning, with those reporting 
higher levels of depression having poorer social functioning. This finding was 
robust in both the small and larger sample.
• Having primary-progressive MS and poorer physical functioning was predictive 
of being out of work.
• A high rating of patient reported executive dysfunction was the strongest 
predictor of depression, followed by a low discrepancy between patient and
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relative reported executive dysfunction (a tendency to over-report executive 
dysfunction) and higher age. When subtype data were excluded to increase the 
sample size, patient reported executive dysfunction was the only predictor of 
depression.
• Patient reported executive dysfunction was the strongest predictor of anxiety, 
followed by having relapsing-remitting-MS.
• The sample was split into individuals who over-report and under-report 
executive difficulties in comparison to their relatives. Over-reporters were more 
likely to have relapsing-remitting MS, have lower age, report higher levels of 
anxiety, report higher levels of memory impairment and have lower levels of 
relative-reported memory impairment, compared to under-reporters.
4.3 METHODOLOGICAL CONSIDERATIONS
4.3.1 Sample size
There was a good response rate, resulting in a large patient sample size, which is a 
strength of the study. There was a smaller response rate for the patients in the Milton 
Keynes sample, which may represent the greater level of disability and longer disease 
duration. There was also a reasonable response rate from the relatives, but the relatives’ 
sample size was smaller because they were selected by a subgroup of patients. There 
was a smaller response rate for the relatives in the Milton Keynes sample, which is 
likely to be due to the fact that reminder letters were not sent for this region.
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The matched pairs comparison of patient and relatives score to produce a discrepancy 
score reduced the sample size. Also the use of subtype data, which was not available for 
44% of the sample, reduced the sample size further. Therefore, the sample size used in 
some of the regression analyses was significantly reduced. This limitation was partially 
rectified by repeating the regression analyses with the subtype data excluded. It was felt 
appropriate to include results using both sample sizes given the slight differences in 
results. The sample was split into two groups: over-reporters and under-reporters. These 
two groups had very small sample sizes (25 and 18). The findings from analyses using 
such small sample sizes need to be interpreted with caution, as the results may not be 
generalisable to the wider MS population.
4,3.2 Sample characteristics
The good response rate increases the likelihood that the sample was representative of 
the MS population as a whole. However, it is not possible to know the characteristics of 
those who did not respond. There may be a response bias in the sample, given that they 
were self-selecting. For example, the responders may be individuals for whom cognitive 
impairment is particularly relevant. Alternatively, those who are severely cognitively 
impaired may be less likely to respond. Two cases were excluded because it was 
obvious that the responses were from their relative’s point of view. In a questionnaire 
sample it is difficult to ensure that all responses are from the participant’s own point of 
view. Unfortunately, this may be more of a problem for those patients who are more 
severely cognitively or physically impaired.
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One difference in this sample was the prevalence of each MS subtype compared to other 
MS populations. There are a number of reasons why the proportions of subtypes may 
differ from other samples. The current sample contained only individuals with clinically 
definite MS, excluding those with probable MS, which some studies (e.g. Foong et al, 
1997) have used. The main difference is that the subtype data in the current study is self- 
reported and, unfortunately, neurological validation of this data was not possible for the 
majority of the sample. It is not possible to verify whether the differences represent true 
differences in the prevalence of subtype, a bias in response or a lack of knowledge on 
the patients’ behalf. It is also possible, however, that in previous studies, neurological 
subtype data was incorrect and that patients themselves may be well-informed of the MS 
subtype they experience. A difference may also lie in the use of terminology; for 
example, the term “benign” is not universally used.
4.3.3 Possible confounding variables
Some patients reported experiencing other illness, which provided some useful data on 
the co-morbidity of other illnesses with MS. However, those other illnesses may affect 
mobility, cognition, health status and mood and this is a possible confounding factor in 
the study. There were also a number of patients experiencing a relapse when they 
completed the questionnaire. Foong et al (1997) reports that cognitive impairment may 
increase during a relapse and return to baseline following exacerbation, and this may 
have affected the reports of cognitive impairment. However, excluding those patients 
reporting a relapse would have significantly reduced the sample size. It is also valuable 
to include these participants, as relapses are a fundamental aspect of the disease. A final 
confounding factor was that no data were collected on the medications or treatments
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patients received. In the comments, some patients referred to physiotherapy, psychology 
and occupational therapy input, or medications, such as anti-depressants, Interferon and 
being on a medical trial for cannabis. Including such data in the analysis would not have 
been feasible. However, it is important to note that they may be factors affecting mood, 
cognitive impairment and health status.
4.3.4 Measures
4.3.4.1 Everyday Memory Questionnaire
This measure was criticised by participants for its lack of a category to indicate “never 
occurs” for the memory lapses (although there is a category for “once a month or less”), 
and some participants added their own category to indicate a particular memory lapse 
had never occurred. Unfortunately, no comparative data are available from a normal 
sample. However, one might expect it to be unusual for individuals to have no lapses in 
some types of memory tasks. This may indicate that the patients have an overly positive 
view of their memory ability, or find it difficult to admit memory difficulties. These 
factors indicate that the measure may lack face validity for this sample.
4.3.4.2 Dysexecutive Questionnaire
The DEX questionnaire was found to have good internal consistency. There were four 
questions that had slightly lower correlation coefficients, although they were still above 
the accepted value. These were “I sometimes get over-excited about things”, “I have 
difficulty showing emotion”, “I tend to be very restless” and “I find it difficult to stop 
myself from doing something”. These questions did not relate as well to a total score 
representing executive dysfunction. The patients and relatives used the maximum range
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on all except one question. However, the mean and median values were very low, 
indicating low levels of reported executive dysfunction in the overall sample. This may 
suggest a restricted variance in DEX scores in the sample. The highest rated questions 
were “I am lethargic and unenthusiastic”, which may relate to fatigue in MS and “I have 
trouble making decisions”, which may reflect anxiety. Also a number of patients did not 
respond to the question, “I have difficulty realizing the extent of my problems and am 
unrealistic about the future”. Given the unpredictability of disease course in MS, this 
question may pose particular difficulty for MS patients.
It was not possible in the current study to investigate whether the five-factor structure 
was replicable for MS patients. Burgess et al (1998) used relatives’ data for their factor 
analysis and the relatives’ sample was not large enough in the current study. Further 
investigation would provide additional information on whether the DEX questionnaire 
is valid for MS samples and whether it has the same structure.
4.3.5 Design
The cross-sectional nature of the study poses some difficulties for interpretation of the 
findings and does not allow questions of causality to be addressed. The questionnaire 
survey only provides a snap-shot picture of the cognitive impairment, mood and health 
status reported by patients and their relatives. This does not provide information on how 
these variables change over time, which, given the progressive and unpredictable nature 
of MS, is likely to be an important factor.
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4.3.6 Biases in self-report data
There are a number of factors that are likely to bias subjective reports. Richardson 
(1996) notes that subjective reports of cognitive impairment are vulnerable to 
observational biases. Self-reports will be biased by how easily different types of 
memory failure can be remembered and those that suffer memory failures are likely to 
forget such failures (Sunderland et al, 1983). Relatives’ reports of cognitive impairment 
will be biased by how easily the memory failure can be observed. The environment is 
also likely to play an important factor. For example, patients may have limited lives as a 
result of MS and, therefore, be exposed to less demanding situations. This was noted in 
some of the questionnaire responses. For example, some patients were unable to rate 
whether they lost the thread of a story in a book because they were unable to read due to 
visual problems. Some patients made comments regarding the use of strategies, such as 
planning events and the use of diaries. This is also likely to affect the reports of 
themselves and others.
MS patients and their relatives may also be reluctant to admit to cognitive impairment in 
the face of progressive physical deterioration (Taylor, 1990). This may lead both to 
under-report the occurrence of cognitive impairment. Relatives may also overlook 
cognitive impairment or attribute it to emotional problems, such as depression (Rao et 
al, 1992). Vinck et al (1997) emphasise that a patient’s mood and an expectation of 
cognitive impairment may have a strong influence on the perception and reporting of 
cognitive impairment. Responses on questionnaires may also be confounded by fatigue 
in MS patients and negative responses may reflect indifference or loss of motivation.
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4.4 INTERPRETATION OF THE FINDINGS
Despite these methodological limitations, a number of interesting findings were 
revealed.
4.4.1 Prevalence of subjective cognitive impairment
MS patients and their relatives reported them as experiencing less executive dysfunction 
than a predominantly TBI population. This is as predicted since MS patients would be 
expected to experience less severe frontal lobe impairment. Levels were low in the 
sample as a whole, but the scores indicated that some individuals reported very low 
levels of executive dysfunction and some reported very high levels of executive 
dysfunction. This is also as expected in a mixed MS sample, given that some individuals 
would be expected to be cognitively impaired and others cognitively intact.
MS patients reported themselves as experiencing similar levels of executive dysfunction 
as that reported in a normal population. This is not as predicted since some MS patients 
would be expected to experience more executive dysfunction than healthy controls. 
Their relatives reported them as experiencing more than in a normal population, which 
is as predicted.
The amount of memory impairment reported by patients was lower than in a neuro­
rehabilitation sample. This finding is as predicted since the neuro-rehabilitation sample 
are more likely to have more severe cognitive difficulties. The amount of memory 
impairment reported by relatives was not significantly different, suggesting that the
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relatives perceive patients as exhibiting the same level of memory difficulties as a more 
severely disabled population.
Both these results indicate that patients report less cognitive impairment compared to 
their relatives. One hypothesis is that these findings indicate a lack of insight or 
awareness for some patients, whereby those with executive dysfunction are less aware 
of their own difficulties and/or those with memory impairment cannot remember their 
memory difficulties. This would fit with the known effects of executive dysfunction, 
which include a lack of insight or denial of problems (Prigatano and Schacter, 1991) and 
the difficulties with memory reporting highlighted by Sunderland et al (1983).
However, there was no significant discrepancy between patients and relatives reports of 
executive dysfunction in the overall sample. This reflects the similar findings of 
Richardson (1996) in relation to reports of memory impairment. This might seem to 
suggest that lack of insight or denial was not an issue in this sample and it is certainly 
not possible to conclude a lack of insight in the sample as a whole. However, the 
amount of discrepancy between patient and relative scores was significantly lower than 
that found in a predominantly TBI population and higher than found in normal controls. 
TBI patients commonly under-report symptoms of executive dysfunction, usually 
attributed to a lack of insight and normal controls have been found to over-report 
executive dysfunction. The reasons for this have not been investigated, although it is 
possible that emotional factors such as anxiety, or social desirability contribute. The 
current group of MS patients as a whole differed from both of these populations.
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These results seem to indicate a mixed population with a range of cognitive impairment 
reported by patients and relatives with some patients experiencing high levels of 
cognitive impairment and others not, and some patients lacking awareness of these 
difficulties and others not. This is as expected given the mixed community sample of 
MS patients. Overall, the pattern seems to indicate a greater similarity to the normal 
population, with non-significant discrepancies overall and low mean values on the two 
measures. However, conclusions regarding the relationship between the patient and 
relatives’ reports of cognitive impairment and actual underlying impairment are not 
possible in the absence of objective assessments.
4.4.2 Differences within the overall group
Using the DEX discrepancy scores, the sample was split into two groups -  individuals 
who over-report and those who under-report executive difficulties in comparison to their 
relatives. Over-reporters were more likely to have relapsing-remitting MS, report higher 
levels of anxiety, report higher levels of memory impairment and have lower levels of 
relative-reported memory impairment. It is possible that the under-reporters are those 
patients who experience executive dysfunction and lack insight into their difficulties, 
although it is not possible to test this out in the current design. There appear to be two 
possible explanations for the second group of over-reporters. This group was 
characterized by high levels of anxiety, by relapsing-remitting MS (more unpredictable) 
and also over-reported memory impairment in comparison to their relatives. It is 
possible that this group comprises more distressed individuals, who find it difficult to 
adjust to the unpredictable course of their disease and are more anxious, leading them to 
over-report symptoms. These patients appear similar to those described by Gervasio and
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Blusewicz (1988) as maintaining a “sick role”. It is also possible that this group 
resembles more the group of normal controls in Burgess et aV s study, who also over­
reported symptoms compared to their relatives. The comments made by some patients 
would seem to tentatively support the former hypothesis, although this requires further 
investigation.
4.4.3 Does subjective cognitive impairment predict health status?
Physical role limitations were found to be correlated with higher levels of self-reported 
memory impairment and executive dysfunction and relative-reported memory 
impairment. These findings suggest a correlation between physical disability and 
perceived and observed cognitive impairment. However, the regression analyses were 
not appropriate, so it is not possible to draw conclusions regarding the predictive power 
of these variables.
Self-reported cognitive impairment was not predictive of social functioning. Depression 
was the only predictor of social functioning, with those reporting higher levels of 
depression having poorer social functioning. Depression is likely to be a disabling 
condition, which will limit an individual’s social functioning. Individuals with 
depression are also more likely to be more withdrawn and lethargic and find it difficult 
to be socially active. However, Smith and Young (2000) found that MS patients who 
were depressed were also more likely to negatively rate their disability. This finding 
may, therefore, reflect those who are depressed perceiving their social functioning as 
low.
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Self-reported cognitive impairment was also not found to be predictive of employment 
status. Individuals with poorer physical functioning and primary-progressive MS were 
more likely to be no longer working. This finding would seem to indicate the primary 
importance of physical functioning in remaining in work. However, one would also 
expect those with primary-progressive MS to have more severe cognitive impairment. 
Therefore, perhaps cognitive impairment is a predictive factor, but the measures are not 
sufficient.
Overall, in the current study, it can be concluded that subjective cognitive impairment is 
not predictive of health status, as measured by social functioning and employment 
status. This supports the findings of Higginson et al (2000), who found that neither self 
or relatives reports of memory impairment were predictive of functional status. In 
previous studies, neuropsychological measures of cognitive impairment have been 
found to be predictive of health status. It is possible, therefore, that subjective measures 
are not adequate in this respect, although further investigation is required to understand 
these differences.
4.4.4 Does subjective cognitive impairment predict mood?
The sample reported significantly higher levels of anxiety and depression than the 
normal population and reported particularly high levels of anxiety. This finding is 
important especially given the wealth of literature on depression in MS and the lack of 
research on anxiety.
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Self-reported executive dysfunction was found to be predictive of depression and 
anxiety. The discrepancy between patient and relative reports was also found to predict 
depression, with a lower discrepancy score being predictive of higher levels of 
depression. This finding may suggest that those who report lower levels of executive 
dysfunction and whose relatives report them as experiencing high levels of executive 
dysfunction (i.e. those who lack insight or deny difficulties) report lower levels of 
depression. This supports the finding of Rao et al (1992), who suggest that lack of 
awareness of symptoms may lead to less distress in some MS patients. These different 
results require further investigation. The results may also indicate that those with 
cognitive impairment have higher levels of depression. An alternative explanation for 
these findings is that depression has an adverse effect on the perception and reporting of 
cognitive impairment (Vinck et al, 1997). When subtype data were excluded to increase 
the sample size, patient reported executive dysfunction was the only predictor of 
depression. This results brings into question the role of insight in predicting mood and 
supports the finding that either those who experience higher levels of executive 
dysfunction experience higher levels of depression and vice versa, or that those with 
higher levels of depression perceive greater cognitive difficulties. In the current design it 
is not possible to clarify these hypotheses.
Anxiety was predicted by higher levels of patient reported executive dysfunction and by 
relapsing-remitting-MS. This suggests that those with relapsing-remitting MS 
experience greater levels of anxiety, as would be expected. Seligman (1975) suggests 
that unpredictable stress (such as would be experienced in a relapsing-remitting disease 
course) leads to a sense of helplessness and has a negative impact on behaviour. The
81
Self-reported executive dysfunction in multiple sclerosis Discussion
role of self-reported executive dysfunction in the prediction of anxiety is less clearly 
understood, in the absence of relative-reported executive dysfunction. It is possible that 
those individuals who experience executive dysfunction experience anxiety as a result. 
However, it is also possible that anxiety leads to an over-reporting of symptoms of 
executive dysfunction.
4.5 THEORETICAL AND CLINICAL IMPLICATIONS
In the current study, self-reported cognitive impairment was found to be related to 
perceived physical limitations, depression, and anxiety. These findings highlight 
relationships between subjective reports of cognitive impairment and mood and health 
status that have not been investigated before in MS. A number of hypotheses have been 
proposed to understand these relationships, but further studies are needed to clarify these 
hypotheses.
One theory which may provide a useful framework for understanding the current 
findings is that of illness representations (Nerenz and Leventhal, 1983), which places an 
importance on the beliefs an individual holds about their illness. An individual can 
conceptualise an illness in terms of identity, causes, consequences, timeline and 
controllability (Weinman, Petrie, Moss-Morriss and Home, 1996) and representations of 
these dimensions are thought to affect the individual’s beliefs, illness behaviour and 
adjustment to the illness. Illness representation theory may be a useful model for 
understanding some of the current findings. For example, certain beliefs, such as the 
expectation, presence, extent or impact of any cognitive impairment or physical
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limitations may affect the perception and reporting of cognitive impairment, health 
status and mood.
In the current design it is not possible to conclude to what extent these subjective reports 
relate to actual cognitive impairment. However, the implications of subjective cognitive 
impairment, irrespective of actual cognitive impairment should be considered. Vinck et 
al (1997) suggest that it is not important whether subjective reports of cognitive 
impairment reflect actual cognitive impairment or perceived cognitive impairment. They 
suggest that if patients are reporting cognitive impairment then this should be addressed 
in any rehabilitation program and that the emotional and social variables associated with 
these reports should be examined and addressed if possible.
The findings indicate that patient and relative responses on the DEX questionnaire are 
internally reliable. The measure potentially provides a useful structured and informal 
measure of executive dysfunction, although at present the self-reports of patients and 
their relatives need to be used in the context of additional neuropsychological 
assessment. In TBI populations, relatives’ reports are considered to be the more valid 
measure of executive dysfunction. In the current study, relative scores were not found to 
be related to health status or mood, however, patient scores on the DEX were found to 
be related to mood. Self-reported DEX scores, therefore, appear to be a useful indicator 
of a patient’s distress. These findings indicate a clinical use for this measure in an MS 
population, but further investigations are required to fully understand its use.
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The findings indicate that some MS patients underestimate their level of cognitive 
impairment (both executive dysfunction and memory impairment) in comparison to 
their relatives whilst others may overestimate their level of cognitive impairment in 
comparison to their relatives. The clinician would be advised to gain reports both from 
the patient and another informant to provide additional information for the clinical 
assessment. This supports the findings of Hermann (1982) who recommends the use of 
relatives’ reports in conjunction with patient reports in the assessment of cognitive 
impairment. The use of both patient and relatives scores in MS may help to clarify any 
problems with insight or misattribution of cognitive symptoms. The findings suggest a 
possible role for a lack of insight and/or anxiety in the reporting of cognitive impairment 
and the discrepancy between patient and relatives reports, which may be useful in 
informing clinical assessment and intervention.
The findings support previous studies, indicating high prevalence rates of anxiety and 
depression in this patient population. This highlights a need for interventions aimed at 
addressing the psychological distress associated with MS. The study also found a link 
between depression and social functioning, which indicates that depressed MS patients 
are likely to experience reduced social functioning. This could be addressed in 
psychological intervention.
4.6 SUGGESTIONS FOR FUTURE RESEARCH
From the results, a number of further hypotheses have been raised which cannot be 
elucidated in the current design, but which require further investigation. In the current 
findings self-reported cognitive impairment was related to other variables, such as
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physical role limitations, depression and anxiety. However, it is not clear whether the 
self-reported cognitive impairment represents actual underlying cognitive impairment, 
or reflects a more negative perception of cognitive ability due to distress. These findings 
need to be investigated further using neuropsychological assessment, which would allow 
a comparison with objective measures of cognitive impairment. The role of lack of 
insight or denial of difficulties also requires further investigation with the use of more 
objective measures.
Future research would also benefit from improved data on subtype, and a larger sample 
size for relatives’ reports. A longitudinal design would be ideal, allowing any changes 
with the progression of the disease to be investigated and causal relationships to be 
explored. Given the complexity of the area and individual differences, future research 
may also benefit from more detailed analysis of qualitative data.
The current study investigated the presence of subgroups within the MS sample of 
individuals who report cognitive impairment in different patterns and can be 
distinguished on certain characteristics. These findings partly address the criticisms of 
previous research, which has used homogenous groups of MS patients and therefore, 
potentially masked relationships between factors. The current study found the apparent 
existence of two groups -  those who over-report and those who under-report executive 
dysfunction compared to their relatives. This finding requires further exploration. It 
needs to be replicated using a larger sample size and the differences between the groups 
explored further. Further investigation would be useful to help understand whether those 
who under-report are experiencing executive dysfunction and lack insight into their
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difficulties, and whether those who over-report are particularly distressed, or similar to 
normal controls. It would be especially interesting to investigate the characteristics of 
the relatives in relation to over-reporters and under-reports to understand the 
discrepancy scores more fully.
An interesting avenue for further research might be to investigate the effects of these 
variables on an individual’s self-concept. Taylor (1996) suggests that in the context of 
progressive disability, patients may lower their levels of aspiration and the reference 
groups with whom they compare their performance. Such factors may affect self- 
reported cognitive impairment and would be a useful adjunct to future research.
Finally, further investigation of the measures is required. The DEX questionnaire would 
benefit from additional psychometric analysis, especially factor analysis to understand 
whether the same factor structure applies in MS as exists in TBI populations. The EMQ 
would also benefit from additional psychometric analysis and improvements to its face 
validity, especially in this patient population.
4.7 CONCLUSIONS
In the context of a heterogeneous patient population with a range of cognitive, physical 
and emotional difficulties, this study aimed to investigate the usefulness of self-reported 
cognitive impairment as an additional tool in clinical assessment. Relationships were 
found between self-reported cognitive impairment and physical limitations, and between 
self-reported executive dysfunction and depression and anxiety. The discrepancy
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between patient and relatives scores was also found to be a potentially useful source of 
information.
In the current design it is not possible to clarify the relationship between the subjective 
reports and actual cognitive impairment. The amount of cognitive impairment reported 
by patients and relatives is likely to be subject to a number of biases and to emotional 
factors and overall, it is probable that several factors are operating in the self-report of 
cognitive impairment by patients and their relatives. However, the self-reports of 
patients and their relatives seem to be potentially useful clinical tools for the assessment 
of MS patients. Further research is required to understand the potential role of self- 
reported cognitive impairment and its usefulness in understanding MS patients’ 
difficulties.
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Stoke Mandeville Buckinghamshire Health Authority
Hospital NHS Trust
Aylesbury Vale Local Research Ethics Committee Mandeville Road, Aylesbury
Buckinghamshire HP21 8AL 
Telephone (01296) 315000 
Direct Line: (01296) 316784
E-mail:
Peter.Mansfield@smh.nhs.uk
31 st August 2001 
Ms L Atkins
Trainee Clinical Psychologist





Re: NCI 074 -  The Pattern and Significance of Self-Reported Executive Dysfunction in Individuals 
with Multiple Sclerosis
I refer to your application to the Local Research Ethics Committee for consideration of the above 
project. I am pleased to inform you that the Committee approves the project on ethical grounds on 
the understanding that:
i. Any ethical problem, arising in the course of the project, will be reported to the 
Committee.
ii. Any change in the protocol will be reported to the Committee.
iii. The Data Protection Act 1998 be adhered to.
iv. There is compliance, throughout the conduct of the study, with good clinical research 
practice.
v. The Committee be informed if the research is discontinued for any reason.
vi. A report be submitted after completion.
vii. Ethical approval is for three years from the date of this letter
Ethical approval by the Committee is not an authority to proceed. You are advised to discuss your 
proposal with all heads of departments and others who might be affected, particularly if there are 
financial and/or staffing implications.
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Milton Keynes
Local Research Ethics Com m ittee









Tel: 01908 660033 
Fax: 01908 669348
Our ref: ARF/MKLREC/28/01 









28/01 The pattern and significance o f seif-reported executive dysfunction in MS
Thank you for attending the meeting on 25th July 2001 to speak on the above protocol. 
Please accept my apology for the delay in responding formally to you.
The protocol was reviewed under LREC procedures and approved. However, the 
Committee did make the following suggestions and recommendations. The introductory 
letter should advise patients that selection for the follow up element of the study will be 
on a random basis and contact details on the questionnaire should be clearer. In 
addition the element of GP involvement should be removed from the study.
I attach a list of the Committee members present for your retention. The Committee 
complies with the ICH GCP guidelines on the composition, functions and operations of 
independent Ethics Committees. The Committee is accountable to Buckinghamshire 
Health Authority. A copy of the constitution of the Committee Is available on request.
If you have any queries or require further assistance, please do not hesitate to contact 
me.




Milton Keynes Local Research Ethics Committee.
FiMCtyn/otniojnoirimmoo/CaoIrthInü
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APPENDIX B
Dear
We are currently undertaking a study about some of the physical and psychological effects of 
multiple sclerosis. You are being invited to take part in this research study. If you are interested 
in filling out the questionnaire please read the enclosed information sheet. After having read the 
information sheet, if you would like to take part in the study, please sign the enclosed consent 
form and complete the questionnaires.
If you have find any difficulty, you may fill in the questionnaire with help from a friend or 
relative or contact Elisabeth Atkins on the above number to complete the questions over the 
telephone.
Please return the completed consent form and questionnaires in the envelope provided. If you do 
not wish to participate please return the blank questionnaire in the envelope provided.
We would also like to hear the views of a family member or friend who knows you well. If you 
are happy for us to send questionnaires to a relative or friend, please write their name and 
address on the questionnaire and we will contact them. Any information supplied by you or 
them will be completely confidential to the researchers.
We look forward to hearing from you and many thanks for your time. Please do not hesitate to 
get in touch with us at the above number if you have any query.
Yours sincerely
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INFORMATION SHEET
Study Title
The pattern of cognitive difficulties reported in multiple sclerosis.
Introduction
You are being invited to take part in a research study about multiple sclerosis. Before 
you decide, it is important for you to understand why the research is being done and 
what it will involve. Please take time to read this information carefully and discuss it 
with others if you wish. Ask us if there is anything that is not clear or if you would like 
more information. Take time to decide whether or not you wish to take part.
Thank you for reading this.
What is the purpose of the study?
People with multiple sclerosis report difficulties in many different areas of their life, 
such as physical symptoms, cognitive (thinking) problems, emotional changes and social 
difficulties. This research aims to investigate the types of difficulties people with 
multiple sclerosis report and the relationship between these difficulties. This will further 
our understanding of the effects of multiple sclerosis.
Why have you been chosen?
Individuals have been selected through the clinics of Dr Briley, Consultant Neurologist 
at Stoke Mandeville Hospital and Dr Hilton-Jones, Consultant Neurologist at Milton 
Keynes General Hospital (names changed for Milton Keynes sample). Individuals who 
have been diagnosed with multiple sclerosis have been contacted for this study.
Do you have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you 
would be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to withdraw at any time and without giving a 
reason.
What would happen to you if you take part?
If you agree to take part you would be asked to complete a number of questions about 
your physical and psychological health and how multiple sclerosis affects you in your 
everyday life. You will also be asked to name someone who knows you well, who could 
also answer similar questions from their point of view.
At a later date, a small number of people may be randomly selected and invited to take 
part in a second stage of the study, which would involve an assessment of cognitive 
functioning or an interview. Further information would be provided at the time and 
people would be able to decide whether they wished to take part or not.
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Would my taking part in this study be kept confidential?
All information will remain completely confidential.
What would happen to the results of the research study?
The results of the study will be written up in the form of a thesis and the intention is to 
also produce academic papers. Although no individual feedback will be available, a 
summary of the results will be sent to all participants who would like to receive one.
Who is organising and funding the research?
The study is being carried out by Elisabeth Atkins (Trainee Clinical Psychologist) as part 
of the research requirements of the Oxford Doctoral Course in Clinical Psychology.
Who has reviewed the study?
This study has been reviewed and approved by the following ethics committees:
• Aylesbury Vale Local Research Ethics Committee
• Milton Keynes Local Research Ethics Committee
Contact for Further Information 





Bucks, HP21 7RD 
Tel: 01296 393319
Please also remember that should the questionnaire raise any personal issues for 
you, you may discuss these concerns with the researcher, or your Consultant.
Thank you  fo r  your time.
Please keep this fro n t sheet fo r  you r information.
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CONSENT FORM
Title of Project:
The pattern of cognitive difficulties reported in multiple sclerosis.
Name of Researchers:
Elisabeth Atkins, Trainee Clinical Psychologist 
Mr John Pimm, Consultant Clinical Psychologist 
Dr Gavin Newby, Principal Clinical Psychologist
1. I confirm that I have read and understand the information sheet for the above study 
and have had the opportunity to ask questions.
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being 
affected.
4. I agree to take part in the above study.
Name of participant Date Signature
Would you like to receive a summary of the results of this study? Yes/ No
PLEASE RETU RN  THIS FO RM  W ITH YOUR QUESTIONNAIRES
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BACKGROUND INFORMATION 
I would be grateful if you would answer the following questions:
Age:______________________
Gender: Male/Female






Number of family members in household:___________
In what year were you diagnosed with multiple sclerosis?
When did you first notice any symptoms of multiple sclerosis?__________
Do you know what type of multiple sclerosis you have? Yes/ No/ Not sure. 





Current or most recent occupation:
Are you working at the moment: Yes/ No
If yes, are you working part-time/ full-time
What are your job details?
Has your work situation changed as a result of multiple sclerosis? Yes/ No 
If yes, in what way (please tick any appropriate boxes)
Changed job □
Changed work tasks within same job □
Reduced hours □
Gone part-time □
Taken sick leave □
How many days in the last year?_____
Taken early retirement through illness □
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What are your highest qualifications:
Do you drive a car? Yes/ No
Has your ability to drive a car changed as a result of multiple sclerosis? Yes/ No
If yes, in what way?.
Do you ever experience a relapse or “flare up” of symptoms of MS? Yes/ No
If yes, are you currently experiencing a relapse or “flare up” of symptoms? Yes/ No
Do you have any other illness? Yes/ No
If yes, please describe:__________________________________________
Please provide a name and address of a relative or friend who knows you well, who would be 




Please provide a telephone number so that the researcher can contact you should there be any 
queries:_________________________________
Thank you.
Please turn over to the questionnaires.
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MEMORY QUESTIONNAIRE
Below are listed some examples of things that happen to people in everyday life. Some of them 
may happen frequently and some may happen very rarely. We should like to know how often on 
average you think each one has happened to you over the past month. We realise that people 
vary from day to day depending on their mood and the exact circumstances they are in. 
However, we would like you to try and give us an OVERALL impression of how often these 
things happen to you. Circle the appropriate number beside each item.
O nce or 
less in the 
last month
M ore  
than once 







M ore  
than once 





m ore in a 
day
1. Forgetting where you have 
put something. Losing things 
around the house.
1 2 3 4 5
2. Failing to recognise places 
that you have often been to 
before.
3. Finding a television story 
difficult to follow.
4. Not remembering a change 
in your daily routine, such as a 
change in the place where 
something is kept, or a change in 
the time something happens. 
Following your old routine by 
mistake.
5. Having to check whether 
you have done something that 
you should have done.
6. Forgetting when it was that 
something happened; for 
example, whether it was 
yesterday or last week.
7. Completely forgetting to 
take things with you or leaving 
things behind and having to go 
back and fetch them.
8. Forgetting that you were 
told something yesterday or a few 
days ago, and maybe having to be 
reminded about it.
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Sam e scale as previous page
9. Starting to read something 
(a book or an article in a 
newspaper, or a magazine) 
without realising you have 
already read it before.
10. Letting yourself ramble on 
to speak about unimportant or 
irrelevant things.
11. Failing to recognise, by 
sight, close relatives or friends 
that you meet frequently.
12. Having difficulty picking 
up a new skill. For example, 
finding it hard to leam a new 
game or to work some new 
gadget after you have practised it 
once or twice.
13. Finding that a word is “on 
the tip of your tongue”. You 
know what it is but cannot quite 
find it.
14. Completely forgetting to 
do things you said you would do, 
and things you planned to do.
15. F orgetting important 
details of what you did or what 
happened to you the day before.
16. When talking to someone, 
forgetting what you have just 
said. Maybe saying “What was I 
talking about?”
17. When reading a newspaper 
or magazine being unable to 
follow the thread of a story; 
losing track of what it is about.
18. Forgetting to tell somebody 
something important. Perhaps 
forgetting to pass on a message 
or remind someone of something.
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Sam e scale as previous page
19. Forgetting important 
details about yourself, e.g. your 
birth date or where you live.
20. Getting the details of what 
someone has told you mixed up 
and confused.
21. Telling somebody a story 
or joke that you have told them 
once already.
22. Forgetting details of things 
you do regularly, whether at 
home or at work. For example, 
forgetting details of what to do, 
or forgetting at what time to do it.
23. Finding that the faces of 
famous people seen on the 
television, or in photographs, 
look unfamiliar.
24. Forgetting where things are 
normally kept or looking for 
them in the wrong place.
25. Getting lost or turning in 
the wrong direction on a journey, 
on a walk, or in a building where 
you have OFTEN been before.
26. Getting lost or turning in 
the wrong direction on a journey, 
on a walk, or in a building where 
you have ONLY BEEN ONCE 
OR TWICE before.
27. Doing some routine thing 
twice by mistake. For example, 
putting two lots of tea in the 
teapot, or going to bmsh/comb 
your hair when you have just 
done so.
28. Repeating to someone what 
you have just told them or asking 
someone the same question 
twice.
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HOSPITAL ANXIETY AND DEPRESSION SCALE
Read each item below and underline the reply which comes closest to how you have been 
feeling in the past week. Don’t take too long over your replies, your immediate reaction to each 
item will probably be more accurate than a long, thought-out response.
I feel tense or “wound up”
Most of the time
A lot of the time
From time to time, occasionally
Not at all
I still enjoy the things I used to enjoy
Definitely as much 
Not quite so much 
Only a little 
Hardly at all
I get a sort o f  frightened feeling as if  som ething  
awful is about to happen
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn’t worry me 
Not at all
I can laugh and see the funny side o f things
As much as I always could 
Note quite so much now 
Definitely not so much now 
Not at all
W orrying thoughts go through my mind
A great deal of the time 
A lot of the time 






Most of the time





I feel as if  I am  slowed down




I get a sort o f frightened feeling like 
“butterflies” in the stom ach




I have lost interest in my appearance
Definitely
I don’t take as much care as I should 
I may not take quite as much care 
I take just as much care as ever
f
I feel restless as if  I have to be on the move
Very much indeed 
Quite a lot 
Not very much 
Not at all
I look forward with enjoym ent to things
As much as I ever did 
Rather less than I used to 
Definitely less than I used to 
Hardly at all
I get sudden feelings o f panic
Very often indeed 
Quite often 
Not very often 
Not at all













This questionnaire looks a t  some o f the difficu lties th a t people  
sometimes experience. W e  w ould  like you to read the  fo llow ing  
statem ents, and ra te  th e m  on a five -p o in t scale according to 
your own experience:
1 I have problems understanding w hat other people mean unless they 
keep things simple and straightforward
□ o  □ . a  n 3 a
Never Occasionally Sometimes Fairly often Very often
! I act without thinking, doing the first thing that comes to mind
□ o  □ ,  n  D b Ba
Never Occasionally Sometimes Fairly often Very often
I I sometimes talk about events or details that never actually happened, 
but I believe did happen
□ o  □ ,  Bi D b Ba
Never Occasionally Sometimes Fairly often Very often
I have difficulty thinking ahead or planning for the future
□ o  □ ,  E L  D b Ba
Never Occasionally Sometimes Fairly often Very often
I sometimes get over-excited about things and can be a bit 'over the 
top' at these times
□ o  D i  EH2 EE3 EJ4
Never Occasionally Sometimes Fairly often Very often
I get events mixed up w ith each other, and get confused about the 
correct order of events
□ 0  □ ,  e:j2 n  Ba
Never Occasionally Sometimes Fairly often Very often
I have difficulty realizing the extent of my problems and am unrealistic 
about the future
D o  D l  EH 2 EZZl 3 O 4
Never Occasionally Sometimes Fairly often Very often
I am lethargic, or unenthusiastic about things
□ 0  □ ,  Bi D b Ba
Never Occasionally Sometimes Fairly often Very often
I do or say embarrassing things when in the company of others
□  0 □ ,  L J 2 E Jb Ej 4
Never Occasionally Sometimes Fairly often Very often
i I really want to do something one minute, but couldn't care less about 
it the next
□ 0  □ ,  E J 2 C Jb B a
Never Occasionally Sometimes Fairly often Very often







J □  2 □ b □ 4
Never Occasionally Sometimes Fairly often Very often
12 1 lose my temper at the slightest thing
...Jo □ , □  2 □ b □  4
Never Occasionally Sometimes Fairly often Very often
13 1 am unconcerned about how 1 should behave in certain situations
□  0  □ , □  2 □ b □  4
Never Occasionally Sometimes Fairly often Very often
14 i find it hard to stop repeating saying or 
started




□  2 □ b □  4
Never Occasionally Sometimes Fairly often Very often
15 1 tend to be very restless, and 'can't sit still' for any length of time
1— 1 F- 1 I___10 l _ ! i □  2 □ b □  4
Never Occasionally Sometimes Fairly often Very often
16 1 find it difficult to stop myself from doing something even if 1 know 1 
shouldn't
1__ !o L J ] □  2 E j 3 [__J 4
Never Occasionally Sometimes Fairly often Very' often
17 1 will say one thing, but will do something different
1 1 ! !; io l _j i □  2 □ b □  4
Never Occasionally Sometimes Fairly often Very often
18 1 find it difficult to keep my mind on something, and am 
distracted
easily
!__ io 1___ii □  2 □ b □  4
Never Occasionally Sometimes Fairly often Very often
19 1 have trouble making decisions, or deciding what 1 want to do
L io : ,Jl □  2 Ljb Ü 4
Never Occasionally Sometimes Fairly often Very often
20 1 am unaware of, or unconcerned about, how others feel about my
behaviour
;__ :0 :___ii □  2 M 3
; I
i M
Never Occasionally Sometimes Fairly often Very often
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HEALTH STATUS QUESTIONNAIRE
The following questions ask for your views about your health, how you feel and how well you 
are able to do your usual activities.
General Health
Please tick one box for each question.






2. Compared to one year ago, how would you rate your general health now?
Much better now than one year ago □
Somewhat better now than one year ago □
About the same □
Somewhat worse now than one year ago □
Much worse now than one year ago □
Health and Daily Activities
3. The following questions are about activities you might do during a typical day. Does 











Vigorous activities, such as running, lifting heavy 
objects, participating in strenuous sports.
Moderate activities, such as moving a table, pushing 
a vacuum cleaner, bowling or playing golf.
Lifting or carrying groceries
Climbing several flights of stairs
Climbing one flight of stairs
Bending, kneeling or stooping
Walking more than a mile
Walking half a mile
Walking 100 vards
Bathing and dressing yourself
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4. During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of your physical health? Answer Yes or No to each 
question.
YES NO
Had to cut down on the amount of time vou spent on work or other 
activities
Accomplished less than vou would like
Were limited in the kind of work or other activities you could do
Had anv difficulty performing the work or other activities (e.g. it took extra 
effort)
5. During the past 4 weeks, have you had any of the following problems with your work 
or other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)? Answer Yes or No to each question
YES NO
Had to cut down on the amount of time vou spent on work or other 
activities
Accomplished less than vou would like
Didn’t do work or other activities as carefully as usual
6. During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered with your normal social activities with family, friends, neighbours or groups? 
Please tick one.
Not at all □
Slightly □
Moderately □
Quite a bit □
Extremely □
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8. During the past 4 weeks how much did pain interfere with your normal work (including 
work both outside the home and housework)? Please tick one
Not at all □
A little bit □
Moderately □
Quite a bit □
Extremely □
Your Feelings
9. These questions are about how you feel and how things have been with you during the past 
4 weeks. For each question please indicate the answer that comes closest to the way you 
have been feeling. Please tick one box on each line





















Did you feel full of life?
Have you been a very nervous 
person?
Have you felt so down in the 
dumps that nothing could cheer 
you up?
Have you felt calm and peaceful?
Did you have a lot of energy?
Have you felt downhearted and 
low?
Did you feel worn out?
Have you been a happy person?
Did you feel tired?
Did you feel rested on waking in 
the morning?
During the past 4 weeks how much has your physical health or emotional problems interfered 
with your social activities (like visiting ffiends/relatives)? Please tick one.
All of the time □
Most of the time □
Some of the time □
A little of the time □
None of the time □
Extremely □
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Health in General
10. Please choose the answer that best describes how true or false each of the following 









I seem to get ill more easily than 
other people.
I am as healthy as anybody I 
know.
I expect my health to get worse.
My health is excellent
Cognitive Function
11. The following questions are about problems you may have experienced with your
‘cognitive functions’. That is, problems with tasks involving memory, concentration or 
problem solving. Please tick one box on each line.





















Have you had difficulty 
concentrating and thinking?
Did you have trouble keeping your 
attention on an activity for long?
Have you had trouble with your 
memory?
Have others, such as family 
members or friends, noticed that 
you have trouble with your 
memory or problems with your 
concentration?
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Quality of Life








d 1 2 3 4 5 6 7 8 9  id
Best possible Worst possible
quality of life quality of life








Please write down any other comments you would like to make. For example, you may 
wish to expand on some of your answers or comment on another aspect of MS.
THIS IS THE END OF THE QUESTIONNAIRE. THANK YOU VERY MUCH FOR 
TAKING THE TIME TO COMPLETE IT. PLEASE POST IT IN THE ENCLOSED 
ENVELOPE WITH YOUR SIGNED CONSENT FORM.
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APPENDIX C
Dear
We wrote to you recently, as a friend/relative of someone with multiple sclerosis, 
inviting you to participate in the above research project on the physical and 
psychological effects of multiple sclerosis. To date we have not received a response from 
you. Your views would be invaluable in helping us understand how we can help people 
with MS.
If you would like to participate in the study we would be grateful if you could return the 
completed questionnaire in the envelope provided as soon as possible. If you would like 
another set of questionnaires, please contact us on the above telephone number. If you 
would not like to participate we would be grateful if you would return the blank 
questionnaire in the envelope provided.
We look forward to hearing from you and many thanks for your time. Please do not 
hesitate to get in touch with us at the above number if you have any query.
Yours sincerely
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APPENDIX D
Dear
We are currently undertaking a study about some of the physical and psychological 
effects of multiple sclerosis. “Patient name” has taken part in this study and agreed for us 
to contact you to gain your views on how multiple sclerosis affects them.
If you are interested in taking part, please read the enclosed information sheet. After 
having read the information sheet, if you would like to take part in the study, please sign 
the enclosed consent form and complete the questionnaires. Return them both in the 
envelope provided. If you do not wish to participate please return the blank questionnaire 
in the envelope provided.
Any information you provide will be completely confidential to the researchers. We look 
forward to hearing from you and many thanks for your time. Please do not hesitate to get 
in touch with us at the above number if you have any query.
Yours sincerely
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INFORMATION SHEET
Same as patients’ information sheet with minor amendments.
CONSENT FORM
Same as patients’ consent form
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BACKGROUND INFORMATION 
I would be grateful if you would answer the following questions:
Age:
Gender: Male/ Female












Other □ (please specify)
Do you live with them? Yes/ No
If no, how often do you see them?
Daily □
Once a week □
Once a month □
Less than once a month □
How many years have you known them?
Did you know them before they were diagnosed with MS? Yes/ No
Thank you.
Please turn over to the questionnaires.
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MEMORY QUESTIONNAIRE 
DEX QUESTIONNAIRE
Same questionnaires as patients with the amended wording for informant completion
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APPENDIX E
Dear
We wrote to you in December inviting you to participate in the above research project on 
the physical and psychological effects of multiple sclerosis. To date we have not 
received a response from you. Your views would be invaluable in helping us understand 
how we can help people with MS.
If you would like to participate in the study we would be grateful if you could return the 
completed questionnaire in the envelope provided as soon as possible. If you would like 
another set of questionnaires, please contact us on the above telephone number. If you 
would not like to participate we would be grateful if you would return the blank 
questionnaire in the envelope provided.
We look forward to hearing from you and many thanks for your time. Please do not 
hesitate to get in touch with us at the above number if you have any query.
Yours sincerely
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